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Glaucoma, a leading cause of blindness, affects over 70 million people 
worldwide, and its incidence is expected to continue to rise with an aging population. 
The exact pathology underlying primary open angle glaucoma (POAG), the most 
prevalent form of glaucoma, is unknown, but an increased intraocular pressure (IOP) is a 
well-established risk factor for POAG. IOP is largely determined by aqueous humor 
production rate and outflow through drainage tissues in the anterior eye, specifically 
through the trabecular meshwork. In POAG, the cellularity of the trabecular meshwork 
(TM) is significantly decreased in comparison to healthy eyes, which presumably leads 
to loss of TM function, higher outflow resistance and, thus, increased IOP. As a result, 
therapies striving to restore TM cellularity could alter glaucoma progression. This 
research will investigate the use of mesenchymal stem cells (MSCs) to restore 
trabecular meshwork function.  
MSC therapies represent a new, largely unstudied, therapeutic approach for the 
TM, and, as such, methods and procedures for assessing differentiation, delivering cells 
to the eye, and assessing these cells’ therapeutic potential for treating POAG are not yet 
established. The overall objective of this thesis was to develop solutions to these 
essential first steps so that MSC therapies can be properly assessed and implemented. 
We first established methods to characterize differences between MSCs and TM cells at 
the RNA, protein, and functional levels for assaying MSC differentiation. For studying 
delivery of MSCs to the eye, we implemented an ultrasound and photoacoustic imaging 
platform for tracking MSC delivery to the TM in real time. Next, magnetic nanoparticles 
were used to label and steer MSC to the TM at high efficiency and uniformity compared 
to passive delivery approaches. Lastly, an improved ex vivo model of POAG was 
 xxi 
 
developed to properly mimic glaucomatous changes in the TM triggered by oxidative 
stress-induced damage.  
Overall, this thesis established methods and procedures needed for developing 
MSC therapies for POAG. Our results allow MSC differentiation to be properly 
characterized, MSC location to be monitored in real-time in the eye, MSC delivery to be 
improved with magnetic nanoparticles, and MSC therapeutic benefit to be assessed 
using a suitable ex vivo model. Future work should assess the potential of MSCs for 





CHAPTER 1.   INTRODUCTION 
1.1 Glaucoma 
Currently one of the major causes of blindness, glaucoma impacts more than 70 
million people worldwide (Cook and Foster, 2012; Quigley and Broman, 2006). This 
number is expected to continue to rise with an aging population, reaching approximately 
80 million by 2020. While there are different types of glaucoma, all are characterized by 
optic neuropathy associated with structural damage to the optic nerve and subsequent 
visual dysfunction (Weih et al., 2001). The most common subset of glaucoma is primary 
open-angle glaucoma (POAG), representing an estimated 74% of glaucoma cases 
worldwide (Quigley and Broman, 2006). POAG is a chronic condition that leads to 
irreversible vision loss. While the pathophysiology of POAG is not yet fully understood, 
an increase in intraocular pressure (IOP) is a well-established risk factor (Weinreb and 
Khaw, 2004).  
1.2 Aqueous Humor Dynamics 
IOP is primarily controlled by aqueous humor production and drainage from the 
anterior segment of the eye. Aqueous humor is produced by the ciliary processes and 
travels from the posterior chamber to the anterior chamber to provide nutrients for the 
avascular tissues of the anterior eye (Figure 1) (Goel et al., 2010). Aqueous humor 
production involves three mechanisms: diffusion, ultrafiltration, and active secretion 
(Gabelt et al., 1995). Diffusion and ultrafiltration are passive processes in which plasma 
solutes are transported between the capillaries and the posterior chamber due to 
concentration and osmotic gradients, respectively (Civan and Macknight, 2004). Active 
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secretion is responsible for as much as 90% of aqueous humor formation (Gabelt et al., 
1995). Active transport of serum solutes against a concentration gradient is facilitated by 
the non-pigmented epithelial cells of the ciliary body through energy-activated protein 
transporters in their cellular membrane (Goel et al., 2010). 
 
Figure 1.  IOP Regulation in the Anterior Chamber. Intraocular pressure is 
determined by the rate of aqueous humor inflow from the ciliary body and by the 
resistance to outflow of this fluid, primarily through the trabecular meshwork (Goel et al., 
2010). 
Aqueous humor drainage occurs passively through two pathways located near 
the anterior chamber angle. The conventional pathway drains through the trabecular 
meshwork across the inner wall of Schlemm’s canal and subsequently into the 
circulatory system (Goel et al., 2010). In the unconventional pathway (also known as 
uveoscleral and/or uveovortex outflow), aqueous humor enters the ciliary muscle, 
passes through the suprachoroidal space, and then either filters across the sclera or is 
uptaken into choroidal vessels (Bill, 1989; Fautsch and Johnson, 2006). The 
conventional pathway is generally believed to be the primary source of aqueous humor 
outflow; however, uveoscleral outflow is difficult to quantify and, while it has been 
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estimated, its outflow contribution is not fully known (Johnson et al., 2017; Weinreb, 
2000).  
Production of aqueous humor has been found to be essentially independent of 
IOP (Acott et al., 2014; Brubaker, 1970, 1991). Further, uveoscleral outflow has been 
found to be relatively independent of IOP compared to the conventional pathway 
(Brubaker, 1991). Thus, increased IOP is almost always due to an increase in outflow 
resistance through the conventional outflow pathway. Conventional outflow resistance is 
predominantly localized to the trabecular meshwork, accounting for approximately 75% 
of outflow resistance, suggesting changes to the trabecular meshwork play a key role in 
IOP elevation seen in glaucoma (Acott and Kelley, 2008; Grant, 1958). 
1.3 Current Glaucoma Therapeutics 
Currently, the primary treatment for POAG is through medication in the form of 
eyedrops which lower IOP. The most commonly used are prostaglandin analogues, 
which decrease resistance through the uveoscleral outflow pathway (non-conventional 
outflow route). Prostaglandin analogues have been associated with intraocular 
inflammation (Tsai and Kanner, 2005). Alternatively, β-blockers are used to decrease 
aqueous humor production. Since aqueous humor provides nutrients to anterior segment 
tissues, lowering production rates could have adverse side effects (Weinreb et al., 
2014). Another key drawback for all eyedrop-based therapeutics is the transient nature 
of changes to IOP, i.e. poor diurnal control of IOP (Weinreb et al., 2014). Transient 
increases in IOP are hypothesized to lead to glaucoma progression (Asrani et al., 2000). 
Lastly, daily topical eye drops have poor patient adherence, further increasing transient 
IOP fluctuations (Gurwitz et al., 1998; Kosoko et al., 1998).  
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More invasive methods for reducing IOP include laser trabeculoplasty, which 
damages the TM to stimulate a tissue remodeling response (Barkana and Belkin, 2007), 
and trabeculectomy filtering surgery, which by-passes the TM by adding new outflow 
channels (Cairns, 1968; Lee and Higginbotham, 2005). These more invasive methods 
are associated with high failure rates, need for follow-up operations, and high 
inflammatory response following surgery (McKinnon et al., 2008; Song et al., 2005). In 
summary, current therapeutic options are unsatisfactory; thus, novel approaches for IOP 
control are needed. Since the trabecular meshwork is the tissue predominantly 
responsible for outflow resistance, this research will focus on trabecular meshwork-
based therapies to reduce IOP levels. 
1.4 Trabecular Meshwork 
1.4.1 Trabecular Meshwork Structure 
The trabecular meshwork (TM) is located in the iridocorneal angle, the location in 
the anterior chamber where the iris and cornea meet (Figure 2). Outflow of aqueous 
humor occurs through the TM’s intricate porous structure toward Schlemm’s canal 
(Figure 2). The innermost portion of the TM is called the uveal meshwork; it is composed 
of beam-like structures containing collagen and elastin fibers, which are covered with a 
continuous layer of TM cells and their basement membrane (Acott and Kelley, 2008) 
(Figure 3). The beam-like structures are discontinuous and the uveal meshwork is 
normally only three beam layers thick in humans, providing a tortuous path for aqueous 
humor to travel through. Further exterior within the TM, the trabecular beams become 
thicker with smaller spaces for fluid to travel; this region is known as the corneoscleral 
meshwork. This denser assortment of beams continues for 8 – 15 layers in humans until 
the final TM region is reached, namely the juxtacanalicular (JCT) or cribiform region 
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(Tamm, 2009) (Figure 3). The JCT is adjacent to Schlemm’s canal and, unlike the other 
regions, contains cells embedded in connective tissue as opposed to cell-covered 
beams (Lutjen-Drecoll, 1999). 
 
Figure 2. The Anterior Chamber and Trabecular Meshwork. (A) The position of the 
anterior chamber and chamber angle (grey box) in a human eye. (B) The chamber angle 
and TM (black box), and (C) further magnified view of the TM and Schlemm’s canal. 
(Kempf et al., 2013). 
1.4.2 Trabecular Meshwork Tissue Function 
Functionally, the TM is responsible for filtering aqueous humor from the anterior 
chamber and generating outflow resistance. The innermost uveal and corneoscleral 
portions of the TM provide little resistance to aqueous humor outflow due to the wide 
openings between beams (Lutjen-Drecoll, 1999). However, the cells in these inner TM 
regions are known to be avidly phagocytic (Buller et al., 1990; Johnson et al., 1989; 
Sherwood and Richardson, 1988). The phagocytic behavior of the inner meshwork is 
important, since removal of debris and particulates before the aqueous humor reaches 
the denser, less porous JCT region is thought to prevent plugging of the JCT. The JCT 
region is where most outflow resistance is believed to be generated. This tissue is 
thought to experience a rapid, continuous extracellular matrix turnover which may play a 




Figure 3. Trabecular Meshwork Microstructure. The three different regions of the TM. 
The direction of aqueous humor flow is from bottom to top in the above micrograph. SC 
denotes Schlemm’s canal, JCT denotes juxtacanalicular tissue, CTM denotes 
cornealscleral TM, UTM denotes uveal TM, and AC denotes the anterior chamber 
(Tamm, 2009). 
While the human TM is continuous around the anterior chamber circumference, 
aqueous humor outflow has been found to be non-uniform or segmental (Swaminathan 
et al., 2014). Studies indicate that as little as one-third of the TM may be actively filtering 
at any one time (Chang et al., 2014). The cause for segmental outflow is still unknown 
but evidence suggests extracellular matrix composition in the JCT, location of collector 
channels, and pores in Schlemm’s canal inner wall play a role (Battista et al., 2008; 
Johnson et al., 1992; Keller et al., 2011; Lu et al., 2011; Overby et al., 2002). Further, 
active filtering regions are altered at physiological pressure (15mmHg) compared to 
lower IOP (9mmHg) in human eyes, suggesting segmental outflow is pressure-
dependent (de Kater et al., 1989; Hann et al., 2005). Finally, the extent of segmental 
outflow is greater in glaucoma patients than in normals (de Kater et al., 1989). 
1.4.3 Trabecular Meshwork Cells 
Although the JCT and inner-TM regions are functionally unique, the resident cells 
are derived from neural crest mesenchymal stem cells during gestation (Abu-Hassan et 
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al., 2014a; Stamer and Clark, 2017; Tripathi and Tripathi, 1989). The inner TM cells of 
the uveal and corneoscleral regions are morphologically endothelial-like but have 
macrophage-like activity to phagocytose debris and pigment (Stamer and Clark, 2017). 
This phagocytic function has been observed in vivo as well as in isolated, cultured cells 
(Johnson et al., 1989). Inner-TM cells also play a role in maintaining openings in the TM 
beam structures by secreting anti-thrombotic factors such as tissue plasminogen 
activator, similar to an endothelial phenotype (Shuman et al., 1988).  
The outer-TM cells, primarily in the JCT region, are morphologically similar to 
fibroblasts. These cells secrete extracellular matrix and degradation enzymes essential 
for tissue remodeling at rates similar to fibroblasts found in sites of wound repair (Keller 
et al., 2009). In addition, the TM cells, primarily in the JCT and corneoscleral regions, 
have contractile properties similar to smooth muscle cells (Dismuke et al., 2014a; 
Stamer and Clark, 2017; Stumpff and Wiederholt, 2000). Alterations to the tissue 
permeability, and, thus, outflow resistance, are related to the cells’ contractile 
capabilities (Llobet et al., 2003).  
1.4.4 Trabecular Meshwork During Glaucoma 
Studies have assessed structural and functional changes to the TM that may 
explain the increased outflow resistance and subsequent elevated IOP observed in 
glaucoma. The cellularity of the TM as a whole has been shown to significantly decrease 
with age, with up to 60% loss by age 80 (Alvarado et al., 1981; Grierson and Howes, 
1987). An even greater decrease in cellularity (approximately an additional 30%) has 
been noted in glaucomatous eyes compared to age-matched eyes (Alvarado et al., 
1984; Liton et al., 2005). The reason for this reduced cell count in glaucoma is not 
known, but oxidative or mechanical stress may play a role (Abu-Hassan et al., 2014a). 
 8 
 
These cellularity changes presumably have important ramifications for the tissue as a 
whole. Other changes to the TM have also been observed in glaucoma. For example, 
the extracellular matrix (ECM) of the TM thickens in glaucoma, indicating abnormal ECM 
maintenance (Tektas and Lutjen-Drecoll, 2009).  
1.5 Regenerative Medicine Therapies 
Due to cell loss in the trabecular meshwork, regenerative medicine approaches 
could be beneficial for treating the TM in glaucoma. Regenerative medicine is a 
therapeutic approach that aims to “replace or regenerate human cells, tissue, or organs 
to restore or establish normal function” (Mason and Dunnill, 2008). One of the primary 
ways regenerative medicine is implemented is through the use of stem cells, a subset of 
cells that are capable of self-renewal and differentiation to different mature cell types 
(Bianco et al., 2001; Kern et al., 2006; Loeffler and Roeder, 2002). Stem cell populations 
with different regenerative capacities have been isolated from both embryonic and adult 
tissues. Based on the origin, the cells’ regenerative potential ranges from the ability to 
differentiate into all adult cell types (pluripotent), to only a limited subset of cell types 
(multipotent). Depending on the regenerative medicine application, the greater 
differentiation potential of pluripotent stem cells may be desirable; however, 
undifferentiated pluripotent stem cells have been found to form teratomas in vivo due to 
uncontrolled proliferation and differentiation (Fong et al., 2010; Hanna et al., 2010). Such 
issues are much less likely when using multipotent stem cell sources, but their lower 
differentiation potential can impose practical limitations. Due to this, rational selection of 
a suitable stem cell population needs to be made for each application.  
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1.6 Stem Cell therapies for the Trabecular Meshwork 
Stem cell therapies for the TM, to date, have focused on three different classes 
of stem cells: native TM stem cells, induced pluripotent stem cells, and mesenchymal 
stem cells.  
1.6.1 Native TM Stem Cells 
A fourth region in the TM, called the insert zone, is located at Schwalbe’s line 
and is not involved in aqueous humor outflow per se (Raviola, 1982). A multipotent stem 
cell-like population has been isolated from this region and characterized (Tay et al., 
2012). These cells, termed TM stem cells or “insert” cells, are believed to play a key role 
in maintaining proper cellularity of the TM as evidenced by laser trabeculoplasty 
experiments showing the majority of TM regeneration occurs in this insert zone (Acott et 
al., 1989). As a result, this cell population is an obvious source for regenerative medicine 
therapies for the glaucomatous TM.   
Du et al. isolated multipotent TM stem cells from human eyes and assessed 
whether differentiation to a TM-like phenotype was possible (Du et al., 2012). TM stem 
cells were treated with bovine aqueous humor or fetal bovine serum for 10 days to 
induce differentiation, at which point cells were assayed for TM-like properties. 
Increased phagocytic activity was observed after both aqueous humor and fetal bovine 
serum treatment, mimicking primary human TM cell activity. Further messenger-level 
changes were detected that were consistent with a TM phenotype. However, since fetal 
bovine serum, a commonly used stem cell media reagent, induced differentiation, TM 
stem cells may be biased toward a TM phenotype (Bieback et al., 2009). Thus, while TM 
stem cells can be successfully differentiated into functional TM cells, the stimulus used 
to differentiate them is unlikely to translate to other stem cell types.   
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A significant drawback to clinical use of therapies based on TM stem cells is the 
reduced cellularity of the glaucomatous TM, strongly suggesting that the insert region 
TM stem cells are too depleted or otherwise somehow unable to repopulate the TM. An 
alternative strategy is to use allogeneic TM stem cells. The TM is immune privileged due 
to the anterior chamber being avascular and aqueous humor containing 
immunosuppressants (Niederkorn, 2002; Treacy et al., 2016). However, corneal 
transplant allografts still suffer from more than 40% rejection rates, suggesting issues 
with allogeneic cell therapies (Sellami et al., 2007). Further, harvesting allogenic TM 
stem cells would be extremely challenging and likely infeasible in a clinical setting.  
1.6.2 Induced Pluripotent Stem Cells 
Alternatively, induced pluripotent stem cells (iPSCs) have been investigated, 
since they can be created autologously, thus overcoming immune rejection issues. 
iPSCs were developed by Nobel laureate Shinya Yamanaka by reprogramming 
fibroblasts through retroviral transduction of 4 genes (Oct3/4, Sox2, c-Myc, and Klf4, 
also known as the “Yamanaka factors”) to an embryonic-like, pluripotent stem cell 
phenotype (Takahashi et al., 2007; Takahashi and Yamanaka, 2006).  
iPSCs have been differentiated to a phagocytic TM-like phenotype by co-culture 
with primary TM cells for 21 days (Ding et al., 2014). TM-like iPSCs were able to restore 
IOP homeostasis in a human organ culture model of glaucoma, demonstrating proof-of-
concept for restoring cellularity of the damaged TM (Abu-Hassan et al., 2014b).  To 
induce reduced TM cellularity, saponin, a plant-derived detergent, was perfused into the 
eye to kill approximately 30 to 40% of TM cells. While the desired reduction in cell 
numbers was achieved, characterization of the effects of saponin on anterior segment 
tissues or its effect on the remaining TM cells was not carried out.   
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Conversely, Zhu et al. used a more conventional transgenic mutant myocilin 
model of glaucoma that leads to endoplasmic reticulum stress and subsequent TM cell 
death (Zhu et al., 2016b; Zode et al., 2011). TM-like iPSCs injected into the mouse eyes 
reduced IOP 6 weeks after injection, indicating TM-like iPSCs restored TM function. 
However, histology revealed that restoration of cellularity was due to increased 
proliferation of native TM cells rather than integration of TM-like iPSCs into the 
meshwork. While some TM-like iPSCs remained in the TM after 12 weeks, many more 
were in off-target tissues such as the cornea (Zhu et al., 2016b). This suggest that the 
driving factor for TM regeneration was paracrine signaling as opposed to direct 
repopulation of the TM by TM-like iPSCs.  
Summarizing the above, iPSC-derived TM-like cells have been shown to reduce 
IOP after introduction into the eye in two different glaucoma models. However, this effect 
may be due to increasing native TM cell proliferation. While these results are promising, 
iPSC-based approaches may not be suitable for clinical treatment of glaucoma patients, 
since aged tissue is known to have reduced proliferative ability, a situation that is 
exacerbated in many disease states. Thus, proliferation of the remaining native TM cells 
in POAG may be muted or inadequate to restore TM function (Barbero et al., 2004; 
McCarron et al., 1987). iPSC-based therapies also suffer from practical limitations, e.g. 
iPSC reprogramming is complex and costly. In addition, iPSCs carry the risk of teratoma 
formation in vivo. These issues impose economic and regulatory hurdles towards 
eventual clinical translation.  
1.6.3 Mesenchymal Stem Cells 
Alternatively, mesenchymal stem cells (MSCs) are being investigated to restore 
TM function. MSCs are multipotent stem cells found in many tissues, e.g. adipose and 
 12 
 
bone marrow tissues (Kern et al., 2006; Zuk et al., 2002).  MSCs are easily isolated 
without lengthy reprogramming or purification processes, as for iPSCs. Furthermore, 
they are already routinely used in clinical application. Based on developmental biology 
studies, trabecular meshwork tissue is believed to be derived from mesenchymal stem 
cells, suggesting mesenchymal-based therapies may be able to restore TM function 
(Cvekl and Tamm, 2004; Gould et al., 2004; Reme and d'Epinay, 1981; Sowden, 2007). 
Two studies to date have investigated MSC therapies for the TM. MSC differentiation 
into functional TM cells was not the focus of these studies. Instead, each study looked at 
MSC paracrine signaling, since paracrine signaling has been shown to play a prevalent 
role in promoting proliferation and tissue function (Gnecchi et al., 2008). First, 
Manuguerra-Gagne et al. injected bone marrow-derived MSCs into a laser-induced 
model of glaucoma in rats (Manuguerra-Gagne et al., 2013). IOP was reduced over the 
course of 20 days following MSC injection, however, stem cells could not be detected in 
the TM after only 4 days. IOP reduction was believed to be due to increased proliferation 
of native TM cells, similar to the situation with TM-like iPSCs (Zhu et al., 2016b). 
Roubeix et al. demonstrated IOP reduction in an episcleral vein cauterization rat 
model of glaucoma following injection of bone marrow derived MSCs (Roubeix et al., 
2015). IOP reduction occurred immediately following delivery, but was not sustained, 
with IOP increasing again after 15 days. Conversely, stem cells were detectable for at 
least 23 days in the TM as well as off-target sites such as the cornea and ciliary 
processes.  
These two studies suggest that MSCs may be suitable for TM regenerative 
medicine therapies. Each study successfully delivered some MSCs to the TM, but 
delivery needs to be further investigated due to conflicting results about stem cell 
retention in the TM. Significant off-target delivery (i.e. cell delivery to tissues other than 
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the TM) was evident in these studies, which could lead to vision-related issues if 
undesired phenotypic differentiation occurred in other ocular locations, such as the 
cornea and lens.  
Lastly, the models used for studying MSC delivery were not ideal for the intended 
application. The laser-induced ocular hypertension model involves applying laser 
irradiation to the TM, which damages the TM and thereby impedes aqueous outflow to 
raise IOP. This approach is suitable for inducing optic neuropathy and studying optic 
nerve head pathophysiology in glaucoma (Levkovitch-Verbin et al., 2002), but is entirely 
unlike the mode of TM damage that occurs in human glaucoma. Loss of intertrabecular 
spaces and trabecular beam contraction are consistently observed in this model, and 
may affect MSC delivery (Levkovitch-Verbin et al., 2002). Alternatively, the episcleral 
vein cauterization model induces elevated IOP by cauterizing multiple episcleral veins to 
block Schlemm’s canal outflow (Shareef et al., 1995). Again, this is unlike what occurs in 
human glaucoma. Further, since the site of increased outflow resistance is downstream 
of the TM in this model, it is an inappropriate model for testing strategies to regenerate 
the TM.  
In summary, MSCs represent a promising cell source for trabecular meshwork 
regeneration; however, to date, few studies have been done with these cells. Additional 
tools are needed to detect differentiation of MSCs to TM-like cells, monitor MSC 
dynamics after injection, improve stem cell delivery to the TM, and properly assess TM 
regeneration in a suitable glaucoma model. This thesis seeks to address these 




CHAPTER 2.   SPECIFIC AIMS 
Due to reduced cellularity in the trabecular meshwork (TM), with concomitant 
loss of functionality during glaucoma, stem cells may offer a novel therapeutic route to 
treat patients with ocular hypertension in glaucoma. Mesenchymal stem cells (MSCs) 
are of particular interest since they can be obtained autologously from adipose tissue 
and can be utilized without lengthy differentiation and purification protocols prior to 
delivery.  However, to date, few studies have investigated using MSCs for repairing the 
TM. Many questions regarding characterizing differentiation, cell delivery to the TM, and 
assessing the therapeutic benefit of mesenchymal stem cells have yet to be addressed.  
This thesis seeks to address these current shortcomings so that MSC therapies 
targeting the glaucomatous TM can be developed. 
Specific Aim 1:  Characterize differences between mesenchymal stem cells and 
trabecular meshwork cells at the RNA, protein, and functional levels 
Before differentiation of MSCs to a TM phenotype is possible, methods for 
confirming differentiation are needed. Human adipose-derived MSCs were compared to 
human TM cells to detect differences between the two phenotypes at the messenger 
RNA (RT-qPCR), protein (western blotting, flow cytometry), and functional 
(phagocytosis, gel contractility) levels. Each method was optimized for detecting 
differences and assessing proper TM cell function. As a result, these methods can be 
utilized to fully define whether MSCs have differentiated to a functional TM-like 
phenotype.  
Specific Aim 2: Implement an ultrasound-photoacoustic imaging protocol for visualizing 
mesenchymal stem cell delivery and retention in the trabecular meshwork 
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Stem cell delivery to any tissue requires optimization and troubleshooting to 
improve delivery efficiency while minimizing unwanted delivery to “off-target” tissues. To 
help optimize cell delivery to the TM, an ultrasound-photoacoustic imaging platform was 
utilized. Ultrasound imaging was able to identify key anatomical landmarks in the porcine 
anterior segment. MSCs were labeled with gold nanospheres so that cells could be 
photoacoustically identified and separated from background signal. With this platform, 
MSCs could be non-invasively tracked during anterior chamber injection and cell delivery 
into the TM. 
Specific Aim 3: Improve mesenchymal stem cell delivery to the trabecular meshwork 
using magnetic nanoparticles 
Aqueous humor outflow through the TM is slow and highly segmental, which is 
problematic for MSC delivery since many cells injected into the anterior chamber tend to 
settle on the anterior iris and lens, while those cells that reach the TM tend to 
accumulate in regions of high flow, which may not be optimal for treating glaucoma. 
Thus, to enhance delivery, MSCs were labeled with magnetic nanoparticles (Prussian 
blue nanocubes [PBNCs]). After injection into the anterior chamber, labelled MSCs could 
be efficiently steered to the TM by a magnetic field in as little as 15 minutes. Further, 
with a suitable magnetic field, MSCs could be steered to the entire TM circumference, 
largely overcoming segmental fluid outflow that impacts conventional MSC delivery. 
Magnetic steering of MSCs thus improves delivery efficiency and distribution to the TM, 
which may be essential for development of optimal glaucoma therapies. 
Specific Aim 4: Development of a Porcine Organ-Culture Glaucoma Model Mimicking 
Trabecular Meshwork Damage 
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Current glaucoma models are primarily focused on creating ocular hypertension 
to induce optic neuropathy, with little fidelity to the clinical pathology that occurs in the 
TM of glaucoma patients. Notably, reduced TM cellularity as seen in glaucoma is not a 
feature of most such models. Instead, existing models permanently damage or clog the 
outflow region, which is not suitable for assessing stem cell therapies to repair the TM. 
Here, we develop a porcine anterior segment organ-culture model using hydrogen 
peroxide to induce oxidative stress in the TM and thus partially decellularize the TM. 
Following hydrogen peroxide treatment, eyes were challenged with increased fluid flow 
to assess the TM’s ability to homeostatically maintain IOP. In response to this challenge, 
control eyes were able to increase outflow through the TM via MMP-mediated 
remodeling, while hydrogen peroxide-treated eyes were not able to do so. Further, live-
dead staining and histology confirmed reduced TM cellularity in treated eyes without 
extensive structural damage to the TM, similar to the situation in human glaucoma. As a 
result, this glaucoma model is suitable to assess the use of MSC-based therapies for 








CHAPTER 3.   Characterize Differences Between Mesenchymal 
Stem Cells and Trabecular Meshwork Cells at RNA, Protein, and 
Functional Levels 
This chapter is adapted from an article published in the Journal of Tissue Engineering 
and Regenerative Medicine:  
Snider, E.J., Taylor Vannatta, R., Schildmeyer, L., Stamer, W.D., and Ethier, C.R. 
(2017). Characterizing differences between MSCs and TM cells: Towards autologous 
stem cell therapies for the glaucomatous trabecular meshwork. J Tissue Eng Regen 






Glaucoma, a leading cause of blindness, is characterized by an increase in 
intraocular pressure (IOP), which is largely determined by resistance to aqueous humor 
outflow through the trabecular meshwork (TM). In glaucoma, the cellularity of the TM is 
decreased, and, as a result, stem cell therapies for the TM represent a potential 
therapeutic option for restoring TM function and treating glaucoma patients. We here 
focus on adipose derived mesenchymal stem cells (MSCs) as a potential autologous cell 
source for TM regenerative medicine applications and describe characterization 
techniques at the messenger (RT-qPCR), protein (western blotting, flow cytometry), and 
functional (contractility, phagocytosis) levels to distinguish MSCs from TM cells. We 
present a panel of 12 transcripts to allow: (i) suitable normalization of RT-qPCR results 
across cell types and after exposure to potential differentiation stimuli; (ii) distinguishing 
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MSCs from TM cells; (iii) distinguishing subtypes of TM cells; and (iv) distinguishing TM 
cells from those in neighboring tissue. At the protein level, dexamethasone-induction of 
myocilin was a robust discriminating factor between MSCs and TM cells, and was 
complemented by other protein markers. Finally, we show that contractility and 
phagocytosis differ between MSCs and TM cells. These methods are recommended for 
use in future differentiation studies to fully define if a functional TM-like phenotype is 
being achieved. 
3.2 Introduction 
Glaucoma, a leading cause of blindness, affects over 70 million people 
worldwide. Its incidence is expected to continue to rise with an aging population (Cook 
and Foster, 2012; Quigley and Broman, 2006). An increased intraocular pressure (IOP) 
is a well-established risk factor for glaucoma (Weinreb and Khaw, 2004), and is the only 
treatable risk factor at present. IOP is largely determined by aqueous humor production 
rate and outflow through drainage tissues in the anterior eye.  Aqueous humor leaves 
the eye primarily through the trabecular meshwork before entering Schlemm’s canal and 
subsequently the circulatory system (Goel et al., 2010).  
The trabecular meshwork (TM), including the inner wall of Schlemm’s canal, is 
known to be the major site of aqueous outflow resistance, and changes in this tissue 
lead to elevated IOP. Further, alterations to outflow resistance are thought to be related 
to TM cells’ contractile capabilities (Llobet et al., 2003). Additionally, the TM removes 
debris from aqueous humor by phagocytosis (Buller et al., 1990; Sherwood and 
Richardson, 1988) to avoid outflow blockage; thus, phagocytosis and contraction are two 
important functional properties of the TM. Structurally, the TM has three main regions 
that differ in outflow resistance, with the inner uveal and corneoscleral regions providing 
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little outflow resistance (Grant, 1963; Tamm, 2009) yet high phagocytic activity (Acott 
and Kelley, 2008), while the outermost juxtacanalicular tissue (JCT) provides much 
higher outflow resistance due to its low porosity (Johnson, 2006; Keller et al., 2009).  
 In glaucoma, the cellularity of the entire trabecular meshwork has been shown to 
be significantly decreased in comparison to age-matched healthy eyes (Alvarado et al., 
1984; Baleriola et al., 2008; Gonzalez et al., 2006; Liton et al., 2005).  This loss of cells 
presumably leads to loss of function in the trabecular meshwork, contributing to higher 
outflow resistance and, thus, increased intraocular pressure. Evidence supporting this 
hypothesis was recently demonstrated by Abu-Hassan et al. who reduced cellularity of 
the trabecular meshwork in human eyes maintained in organ-culture, which led to a loss 
of IOP homeostasis (Abu-Hassan et al., 2015). Thus, therapies seeking to restore the 
cellularity and function of the trabecular meshwork could potentially have therapeutic 
benefit for glaucoma patients. 
Several studies have investigated the use of fibroblast-derived induced 
pluripotent stem cells (iPSCs) to create TM-like cells to repopulate the TM (Abu-Hassan 
et al., 2015; Ding et al., 2014) . However, iPSCs technology is complex and costly and 
poses challenging regulatory hurdles to bring these therapies into practice (Fong et al., 
2010; Neofytou et al., 2015; Reisman and Adams, 2014). Here we consider the 
alternative approach of using adult-derived mesenchymal stem cells (MSCs). While 
MSCs are found in many adult tissues (e.g. adipose tissue) and are commonly used in 
clinical settings with fewer regulatory hurdles than iPSCs, MSCs have less differentiation 
potential than iPSCs. Fortunately, the trabecular meshwork appears to be derived from 
mesenchymal stem cells, suggesting MSCs may be capable of reaching a TM lineage 
(Cvekl and Tamm, 2004; Reme and d'Epinay, 1981). Furthermore, preliminary efforts 
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have shown evidence that MSCs are capable of differentiating to a TM-like phenotype 
(Snider et al., 2016; Zhou et al., 2015).  
TM cells have been compared to an MSC phenotype previously to determine if 
TM cells possess stem cell-like characteristics (Morgan et al., 2014). In contrast, for 
MSC-based regenerative therapies for the trabecular meshwork characterization 
methods to thoroughly describe the TM phenotype and distinguish undifferentiated 
MSCs and TM cells are required. TM cells have previously been characterized by their 
RNA and protein expression profile as well as unique functional attributes; and these 
characteristics will be used for comparison against MSCs. The ideal characterization 
methods should: (i) easily and quantitatively distinguish MSCs from TM cells, (ii) be 
consistent with common methodologies used to characterize TM cells currently, (iii) be 
relatively high-throughput, and (iv) assess functional outcomes. We here describe a set 
of characterization assays that meet these criteria. 
3.3 Materials and Methods 
3.3.1  Mesenchymal Stem Cell Sourcing and Characterization 
Human adipose derived MSCs (Lonza) were grown in α-minimum essential 
medium supplemented with 20% fetal bovine serum (FBS), penicillin, streptomycin, and 
L-glutamine. At 80-90% confluency, MSCs were detached using 0.05% Trypsin/EDTA 
(w/v) and seeded in fresh cell-culture T75 flasks at a seeding density of 5,000 cells/cm2.  
In all experiments, MSCs were used at passage numbers five or six. Each MSC donor 
strain was validated by Lonza for expression of MSC surface markers (CD13, CD29, 
CD44, CD73, CD90, CD105, and CD166) and minimal expression of negative MSC 
markers (CD14, CD 131, CD45).  
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After MSC expansion, stem cells were further characterized two ways. First, each 
MSC donor strain was exposed to adipogenic, chondrogenic, and osteogenic medium 
(Life Technologies) for 1, 2, and 3 weeks respectively to test trilineage potential. All 
samples were fixed at respective time points and stained with Oil Red O (lipids, 
adipogenic), Alcian Blue (glycosaminoglycans, chondrogenic), and Alizarin Red 
(calcium, osteogenic), respectively.  Each donor strain was also characterized for a 
known MSC surface marker (CD90) and negative MSC marker (CD45) using flow 
cytometry (Chamberlain et al., 2007) after resuspending cells in fluorescently conjugated 
CD90/CD45 or respective isotype solutions for 30 minutes (R&D Systems). Flow 
cytometry, using an LSR II (BD Biosciences), was performed until at least 10,000 cellular 
events were recorded for stained, isotype and unstained controls. To quantify flow 
cytometry data, positive gates were configured on histogram plots so that less than 0.5% 
of isotype fluorescence gated positively. Stained samples were compared using the 
same gate configuration to determine the percentage of cells showing a shift in 
fluorescent intensity, indicating surface marker expression. 
3.3.2 Trabecular Meshwork Cell Sourcing and Characterization 
Human trabecular meshwork (TM) cells were isolated as previously described 
(Stamer et al., 1995), and grown in Dulbecco’s Modified Eagle Medium (DMEM, 1g/L 
glucose) with 10% FBS, penicillin, streptomycin, and L-glutamine. At approximately 80-
90% confluency, TM cells were detached with 0.05% trypsin/EDTA and seeded onto 
fresh T75 flasks at 5,000 cells/cm2. TM cells were characterized as previously described 
through morphological assessment, contact inhibition, and dexamethasone induction of 
myocilin (Clark et al., 2001; Stamer et al., 2000; Stamer et al., 1995), and used in 
experiments at passage number five to seven. Based on morphological assessment, TM 
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cell donor strains with high JCT-like cell content were denoted as JCT/TM cells instead 
of TM cells, which were more uveal/corneoscleral-like. 
3.3.3 Reverse Transcription Quantitative PCR (RT-qPCR) 
RNA was isolated from cells using TRIzol reagent (Life Technologies) and further 
purified using Aurum Total RNA Mini Kit per the manufacturer’s protocol (Bio-Rad). RNA 
concentration and purity were determined using a Nanodrop 2000C spectrophotometer 
(Thermo-Scientific). Reverse transcription to clonal DNA (cDNA) was performed on 1μg 
RNA samples per the manufacturer’s protocol (Bio-Rad). cDNA samples were analyzed 
against a panel of twelve primer pairs (Table 1) (Du et al., 2012; Spandidos et al., 2008; 
Spandidos et al., 2010; Wang and Seed, 2003; Ye et al., 2012). SYBR green reagent 
(Quantabio) was used to quantify DNA amplification in real time throughout the PCR 
cycle (StepOnePlus Real Time PCR System, Applied Biosystems). The resulting cyclic 
threshold (CT) values were normalized to the geometric mean of three reference genes 
(GUSB, YWHAZ, and TATA BP; see below) and further normalized against untreated 









Table 1. Primer Sequences Used in RT-qPCR Experiments. Primers are organized 
based on different categories (e.g. reference, TM cell marker). Primers were selected 
from indicated references or designed using Primer-Blast when indicated. Sequences 
selected from PrimerBank database show corresponding PrimerBank IDs. 
 
3.3.4 Dexamethasone Induction of Myocilin 
Isolated TM cells are commonly characterized by measuring the upregulation of 
myocilin protein following dexamethasone (DEX) treatment (Stamer et al., 2000; Stamer 
et al., 1995). Compared to other ocular cells, TM cells uniquely, and dramatically 
upregulate myocilin (MYOC) in response to glucocorticoid treatment (Clark et al., 2001). 
Thus, the same methodology was applied to characterize MSCs as they differentiated 
into TM cells. Cells were treated with 100nM DEX (Sigma) in media for 7 days, changing 
media every three days. Additional control cells remained untreated for 7 days with 
similar feeding regimen.  MYOC levels were detected in two ways: by western blotting 
and by flow cytometry.  
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3.3.5 Western Blotting 
Protein was isolated from cell monolayers using ice-cold RIPA buffer 
supplemented with Halt™ Protease Inhibitor Cocktail (Thermo-Scientific) after washing 
with PBS to remove media protein. Isolated protein was then quantified by micro 
bicinchoninic acid assay (BCA) per the manufacturer’s protocol (Thermo-Scientific). 
Samples were diluted and 4x Laemmli Sample Buffer (Bio-Rad) with 50μM Dithioethriol 
(DTT) was added so that protein concentrations were equal across all samples 
(20μg/sample). To denature proteins, samples were heated at 95oC for 5 minutes. 
Finally, samples were added to Protean-TGX stain-free 8-16% polyacrylamide gels (Bio-
Rad) for SDS-PAGE at 150V, 45 minutes.  
Following SDS-PAGE, gels were placed on a UV transilluminator plate for 10 
minutes to activate the stain-free total protein gel indicator. Stain-free gels contain trihalo 
compounds which bind to tryptophan residues through a UV-catalyzed reaction, leaving 
a fluorescent signal where protein exists in the gel (Ladner et al., 2004). After incubation, 
samples were imaged with an Amersham Imager 600 scanner (GE Healthcare) to 
confirm total protein staining. Next, gel proteins were transferred to a polyvinyl difluoride 
(PVDF) membrane using a Trans-blot Turbo Transfer system (Bio-Rad; 3 minutes, 25V). 
Membranes were blocked in Odyssey® TBS Blocking Solution (LI-COR Biosciences) for 
1 hour at room temperature and incubated with MYOC primary antibody (Santa-Cruz 
Biotechnology N-15, 1:2000 dilution factor [DF] in blocking solution) overnight, 4oC. After 
washing with TBS-Tween20, AlexaFluor 680 conjugated secondary antibody (1:10000 
DF) was added for 1 hour at room temperature. Blots were imaged with an Amersham 
Imager 600 scanner for MYOC labelling and total protein fluorescence. MYOC levels 
were normalized to the total protein stain using ImageQuant software (GE Healthcare).  
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3.3.6 Flow Cytometry 
3.3.6.1 Intracellular Marker Approach 
Adherent cells were detached from tissue-culture plastic using 0.05% 
Trypsin/EDTA after washing off residual media with PBS. After 5 minute (37oC) 
incubation, Trypsin was neutralized and cell samples were collected, centrifuged, and 
resuspended in 1% paraformaldehyde (PFA) for 10 minutes. Subsequently, samples 
were washed with FACS buffer (PBS supplemented with 5% FBS and 0.02% Sodium 
Azide) and resuspended in 100μL antibody solution (antibody information provided in 
Table 2) containing 0.5% saponin FACS buffer for 30 minutes. Following multiple wash 
steps in 0.5% saponin FACS buffer, cells were resuspended in AlexaFluor 488 (Life 
Technologies) or PerCp-Cy5.5 (Santa Cruz) conjugated secondary antibody solution 
(1:500 DF) for 30 minutes. After additional wash steps, cells were resuspended in 500μL 
FACS buffer.  
Table 2. Flow cytometry Primary Antibodies and Respective Isotypes. Dilution, 
supplier, and catalog numbers for each antibody and isotype used for flow cytometry 
experiments are shown.                                                                
 
3.3.6.2 Surface Marker Approach 
Live cells (not fixed) were resuspended in 100µL fluorescently-conjugated 
antibody (Table 2) solution in FACS buffer on ice for 30 minutes. Multiple wash steps 
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with FACS buffer were then performed, followed by resuspension in 500µL FACS buffer. 
Samples remained on ice until analysis.  
3.3.6.3 Flow Cytometry Data Analysis 
Data was collected with an Accuri C6 (BD Biosciences) at 35µl/min flow rates 
until at least 10,000 cellular events were recorded. Median fluorescent intensities (MFI) 
values for each marker expression were used for comparison between samples. For 
normalization and assessing non-specific antibody binding, unstained and isotype 
controls (Table 2) were also run for each sample type.  Unstained MFI values were 
subtracted from all stained samples to account for differences in auto-fluorescence 
across cell type and donor strain (Overton, 1988). For isotype controls, normalized MFI 
values were compared against stained samples to confirm higher MFI values in stained 
samples.   
3.3.7 Collagen Gel Contractility 
As a functional outcome measure, cell contractility was determined using a 
collagen gel contraction assay since trabecular meshwork cells have been shown to 
possess a dynamic contractile range (Dismuke et al., 2014b). Cells were resuspended in 
DMEM (no FBS) at 9 x 105 cells/mL. Collagen type I (3mg/mL, 1% acetic acid, calf skin, 
MP Biomedical) was added to cells at a 1:2 volume ratio (collagen:cells) followed 
immediately by a pretitrated volume of 1M sodium hydroxide to neutralize the acidity. 
Collagen gels (1mg/ml, 6x105 cells/mL) were then cast in 96 well plates at 80μL gel 
solution per well. After 20 minutes to allow gelation, an equal 80µL volume of serum-free 
media was added to provide nutrients needed for attachment while minimizing 
proliferation. After 24 hours, gels were released from the walls of the 96-well plate using 
a pipette tip. Images of each gel were taken every hour for approximately 12 hours after 
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release; images were also taken the following day to record steady-state gel area. Using 
ImageJ, gel area was quantified for each image to determine the magnitude of gel 
contraction. 
3.3.8  Phagocytosis Assessment 
A second functional property measured was phagocytosis. TM cells have been 
shown to be actively phagocytic in vivo, presumably to remove particulate/cellular debris 
to avoid clogging the meshwork (Buller et al., 1990; Sherwood and Richardson, 1988). 
To quantify phagocytosis, pHrodo green e.coli BioParticles (LifeTechnologies) were 
used following previously developed methods (Gagen et al., 2013). pHrodo particles 
have low fluorescence when at or near neutral pH levels, but increase in fluorescence at 
low pH, such as in lysosomes. Increases in fluorescence should, thus, be associated 
primarily with phagocytosed particles instead of particles attached extracellularly to cell 
membrane. Cells were seeded at 50,000 cells/cm2 onto 48 well plates in Hanks’ 
balanced salt solution (HBSS) supplemented with 5% FBS and 2mM L-glutamine. After 
24 hours, pHrodo particles were reconstituted in HBSS media in enough volume to treat 
2 million cells per vial. Particles were vortexed, sonicated, and added to cells.  
After a 4 hour incubation at 37oC, particles were removed and cells were 
detached with 0.05% Trypsin/EDTA. Samples were centrifuged and resuspended in 
400µL FACS buffer and placed on ice. Data was collected with a BD Accuri C6 flow 
cytometer at 35µL/min. For normalization and accounting for auto-fluorescence, 
unstained samples were also run for each donor strain. Unstained MFI values were 
subtracted from phagocytically-challenged sample MFI values. 
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3.3.9  Statistics 
Triplicate samples were run for each cell donor strain for all experiments. 
Furthermore, at least three donor strains were tested for MSCs and at least two TM cell 
donor strains for each characterization approach. Two-way ANOVA was used to test for 
significant differences between MSCs and TM cells. For all experiments, p-values less 
than 0.05 were considered as statistically significant. 
3.4 Results 
3.4.1 Mesenchymal Stem Cell Characterization 
MSCs after expansion (passage 4 or 5) were characterized for a known MSC 
surface marker, CD90 (Figure 4a). Each MSC donor strains showed greater than 95% 
positive staining for CD90 when gated vs. isotype controls, in agreement with MSC 
characterization standards (Dominici et al., 2006). In addition, a known negative MSC 
surface marker, CD45, was tested and exhibited minimal expression in all MSC donor 
strains (Figure 4b). Furthermore, each MSC donor strain showed multi-lineage potential 
after induction toward adipogenic, chondrogenic, and osteogenic phenotypes (Figures 




Figure 4. Mesenchymal Stem Cell Characterization. (A-B) Surface marker 
characterization by flow cytometry for MSC markers: (A) shows CD90, a positive marker 
and (B) shows CD45, a negative marker. Stained samples were compared against 
unstained and respective isotype controls to properly gate samples, as shown. (C-E) 
MSCs were stained with oil red O (lipids), alcian blue (glycosaminoglycans) and alizarin 
red S (free calcium) after treatment with adipogenic (C), chondrogenic (D), and 
osteogenic (E) differentiation stimuli. Images taken at 1, 2, and 3 week time-points, 
respectively. 
3.4.2 Reverse Transcription Quantitative PCR  
3.4.2.1 Identifying Suitable Reference Genes  
To identify suitable reference (internal control) genes for this study, we used 3 
MSC donor strains, 4 TM cell donor strains, and considered the effects of possible 
differentiation stimuli (such as mechanostimulation and hypoxia). Including all replicates, 
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33 different experiments were run for 7 potential reference genes (GUSB, YWHAZ, 
TATA BP, B-Actin, GAPDH, cyclophilin, and 18s rRNA). Based on methods published 
(Vandesompele et al., 2002) and corresponding GeNorm software, the normalization 
stability for each reference gene was tested. The geometric mean of three markers 
(GUSB, YWHAZ, TATA BP) was found to provide the most stable normalization (Data 
not shown). For all subsequent RT-qPCR experiments, the geometric mean of these 
three genes was used for normalization of message levels.  
3.4.2.2 Gene-expression Analysis of MSCs vs TM Cells 
To facilitate quantification, transcript expression levels were first normalized to 
the average of three reference genes as described above, and then further normalized 
to average expression of the same gene across three undifferentiated MSC donor 
strains. Based on these studies, five TM markers, tPA, LDL Receptor, CHI3L1, MGP, 
and MYOC, were selected to distinguish between TM cells and MSCs, with each 
expressed more highly in TM cells (Figure 5a). Furthermore, levels of αB-crystalline, a 
known juxtacanalicular tissue (JCT) marker, and VE-Cadherin, a Schlemm’s canal 
endothelial cell marker, were assessed as a way to distinguish nearby ocular tissues vs. 
TM cells (Figure 5b). Lastly, two MSC markers, Muc1 and CD105, were identified which 
were consistently more highly expressed in MSCs compared to TM cells (Figure 5c). All 
of these markers were selected as they consistently showed MSC vs. TM cell 





Figure 5. mRNA Transcript Levels in TM cells, Measured by RT-qPCR and 
Normalized Against MSC Transcript Levels. Fold-difference mRNA expression levels 
in four TM cell strains (TM 120, TM 123, JCT/TM 129, JCT/TM 086 [denoting higher JCT 
content in donor strains]) relative to the average expression in 3 MSC strains are shown 
for: (A) TM cell, (B) Schlemm’s canal and JCT cell, and (C) MSC markers. Data was first 
normalized to the geometric mean of three reference markers (GUSB, TATA BP, and 
YWHAZ) in each sample, as described in the text. Error bars denote standard deviations 
(n=3 replicates for each strain). 
3.4.3 Dexamethasone Induction of MYOC 
3.4.3.1 Western Blot Analysis 
MYOC protein levels from cell lysates were quantified with and without DEX 
treatment for three MSC and four TM cell donor strains. For each donor strain, MYOC 
(55kDa) band intensity was normalized against total protein fluorescent signal to account 
for loading variability (Figure 6a). Each MSC and TM cell donor strain tested was 
consistent across their respective groups (Figure 6b), with TM cells showing 
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approximately 4-fold increased MYOC expression after DEX treatment whereas MSCs 
showed minimal changes in expression (p < 0.002; Figure 6c).  
 
Figure 6. Western Blot Analysis for Dexamethasone Induction of Myocilin in TM 
Cells and MSCs. (A) Representative western blot against myocilin (red) and total 
protein (blue) for TM cells and MSC with and without dexamethasone. Molecular weight 
markers (labeled “ladder” in the figure) are shown in red. (B) Quantification of myocilin 
expression changes after dexamethasone treatment for four TM cell and three MSC 
donor strains (n=3 replicates for each strain). The vertical axis is normalized myocilin 
band intensity after DEX treatment divided by band intensity in control (vehicle-treated) 
cells. (C) Average values for TM cells and MSC (p < 0.002). Error bars denote standard 
deviation throughout. 
3.4.3.2 Flow Cytometric Analysis 
Intracellular MYOC protein levels were further quantified within fixed cells by flow 
cytometry. DEX-treated and untreated samples were prepared in triplicate for each 
donor strain and compared against unstained and isotype controls to confirm MYOC-
specific staining (Figure 7a). Consistent increases in MYOC expression (~1.9 fold) after 
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DEX in all TM cell donor strains and slight decreases in MSC donor strains (~0.7 fold) 
were seen (Figure 7b).  As was the case for Western blots, these differences were 
statistically significant (Figure 7c, p < 0.0001).  
 
Figure 7. Flow Cytometric Analysis for Dexamethasone Induction of Myocilin in 
TM Cells Versus MSCs. (A) Representative histograms for myocilin expression in 
isotype controls (red), untreated cells (blue), and DEX-treated samples (green). (B) 
Quantification of myocilin expression (median fluorescence intensity) changes after 
dexamethasone treatment for four TM cell and three MSC donor strains (n=3 replicates 
for each strain). (C) Average ratio value for TM cells and MSCs (p < 0.0001). Error bars 
denote standard deviation. 
3.4.4 Additional Protein Markers 
Protein expression of differentially expressed mRNAs were assessed since gene 
expression analysis by RT-qPCR doesn’t necessarily translate to protein expression. 2 
TM cell donor strains and 3 MSC cell donor strains were examined for the expression of 
CHI3L1 and tPA, intracellular markers for TM cells, as well as CD73 and CD90, cell 
surface markers for MSC cells. (Figure 8). CHI3L1 and tPA were consistently expressed 
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at higher levels in TM cells while CD73 and CD90 were more highly expressed across 
tested MSC donor strains. 
 
Figure 8. Protein-level Characterization of MSCs and TM Cells. Shown are select 
protein markers for TM cells and MSCs using flow cytometry. Average fluorescent 
intensity values for TM cells (n=2 donor strains) and MSCs (n=3 donor strains) are 
shown for four protein markers. Error bars denote standard deviation, and p-values are 
shown on the plot. 
3.4.5 Collagen Gel Contractility 
Cells grown in free-floating collagen gels were allowed to reach a homeostatic 
contraction state to assess cell contractility (Figure 9a). At the point of gel release from 
sides of culture plate wells, the gel immediately began to contract (Figure 9b). After 
sufficient time (8+ hours), a steady state gel size was reached. Consistent and 
significant differences between gels seeded with TM cell and MSC donor strains were 
observed (55% vs. 15% initial gel area, respectively) after reaching steady state (8+ 




Figure 9. Comparison of TM Cell and MSC contractility. (A) Schematic diagram of 
collagen gel contraction assay. (B) Average change in collagen gel area relative to initial 
gel size for TM cells and MSCs during the first seven hours after release from the well. 
(C) Percent of original gel area for TM cells and MSCs at equilibrium (>8 hours, p < 
0.0005). Three TM cell and MSC donor strains were used. Error bars denote standard 
deviation. 
3.4.6  Phagocytosis 
pHrodo particles were added to densely seeded cell monolayers for 4 hours to 
allow time for phagocytosis and an increase in fluorescence intensity as particles 
reached lysosomes (Figure 10a). By flow cytometry, three MSC and TM cell donor 
strains were quantified for phagocytic activity after 4 hours, showing an approximately 
2.25-fold greater fluorescence signal in all TM cell vs. MSC donor strains (Figure 10b). 
This difference was statistically significant when comparing average TM cell and MSC 





Figure 10. Comparison of TM Cell and MSC Phagocytic Activity. (A) Schematic 
diagram of phagocytic assay and pHrodo particles’ fluorescent properties. Using this 
assay (B), fluorescent intensity from flow cytometry after four hours’ incubation is shown 
for individual TM cell and MSC donor strains. (C) Average values for TM cells and MSCs 
(p < 0.0001). Error bars denote standard deviation. 
3.5 Discussion 
MSC-based therapies to restore the cellularity and functionality of the trabecular 
meshwork represent a viable novel strategy to treat and manage ocular hypertension, a 
key feature of glaucoma. To confirm MSCs are capable of differentiating to a TM-like 
phenotype, methods to properly characterize differentiated MSCs for TM-like 
characteristics are first required. Using a series of characterization approaches, we here 
present methods that for the first time assess messenger, protein and functional level 
differences between undifferentiated MSCs and TM cells. 
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For a robust, high-throughput method, a panel of genetic markers were proposed 
and tested for message-level differences between MSCs, TM cells, and other 
neighboring eye phenotypes. DEX induction of MYOC, commonly used to identify TM 
cells isolated from tissue, was markedly different when comparing TM cells and MSCs, 
as shown by western blot and flow cytometric analysis. Additional TM cell and MSC 
protein markers were further characterized by flow cytometry. Finally, functionality was 
tested using a gel contractility assay and a phagocytosis assay where consistent 
differences were found between TM cells and MSCs. Overall, this series of assays 
provides characterization on several levels to broadly assess MSC differentiation to a 
TM-like phenotype, and is an important step toward developing possible MSC-based 
glaucoma therapies.  
At the message level, RT-qPCR analysis was performed to develop a gene panel 
of differentially expressed and control mRNAs for MSCs and TM cells. This approach 
provided a robust characterization of differentiation, since a panel of message-level 
markers could be assayed across a number of samples at once. For suitable 
normalization of PCR experiments, we determined reference or internal control genes for 
our specific application. Since differentiation pathways for MSCs to TM cells are 
currently unknown, we examined changes in the levels of seven different reference 
genes across a number of MSC and TM cell donor strains, as well as after exposure of 
these cells to several possible differentiation stimuli (i.e. mechanostimulation, hypoxia).  
The geometric average of three markers (YWHAZ, TATA BP, GUSB) was found to be 
most consistent. The geometric mean was used instead of the arithmetic mean since it 




With suitable normalization established, we assessed multiple messages for TM 
cells, MSCs, and other relevant ocular cell types to identify transcripts consistently 
expressed in the MSC and TM cell donor strains used. Specifically, a panel of twelve 
markers was selected: 3 reference, 5 TM cell-specific, 2 MSC-specific, 1 JCT-specific, 
and 1 Schlemm’s Canal endothelial cell-specific. We included a JCT marker, αB 
Crystallin, since even though the JCT region is considered part of the TM, resident JCT 
cells differ morphologically and functionally from the remainder of the TM, making it 
relevant to know if a more JCT-like phenotype (myofibroblast) was forming vs. an 
endothelial-like phenotype characteristic of the inner portion of the TM (Braunger et al., 
2015; Stamer and Clark, 2016). Similarly, Schlemm’s canal endothelial cells lie 
immediately adjacent to the TM and, as a result, a marker was selected to distinguish a 
Schlemm’s canal phenotype vs. TM cell phenotype. This panel showed clear expression 
differences between MSCs and TM cells, and RT-qPCR was attractive for differentiation 
characterization since assessing multiple markers in a single experiment allowed for 
high-throughput screening, not possible in standard protein-level characterization 
methods. Furthermore, messenger level analysis is much more sensitive that standard 
protein expression assays, capable of detecting signals in very small quantities of 
cellular RNA (Iscove et al., 2002). 
At the protein level, we induced MYOC expression with DEX treatment. As 
shown first by western blot analysis, differences in MYOC expression following DEX 
treatment were consistently found between TM cells and MSCs. One issue with western 
blotting, particularly in differentiation studies, is identifying suitable markers for loading 
control normalization. Rather than focus on a single protein marker, we normalized using 
total protein labeling with trihalo compounds, which bind to protein residues after UV 
activation. This approach has been shown to be more robust and reliable compared to 
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standard single loading control normalization(Gilda and Gomes, 2013).  Compared to 
other total protein stains, trihalo compounds are loaded in the gel prior to SDS-PAGE 
meaning no staining steps are needed and total protein signal is obtained quickly by 2.5 
minutes of UV activation.  
DEX induction of MYOC was also investigated using flow cytometry. Similar to 
western blot analysis, consistent results were found, with TM cells increasing their 
MYOC expression after DEX treatment while MSCs decreased their MYOC expression. 
Although western blotting is more traditional, flow cytometry is attractive for several 
reasons: it allows for normalization at a single cell level and for simple multiplexing to 
other possible markers of interest. Also, due to single-cell events, heterogeneity can be 
separated out in experimental samples, possibly allowing for quantification of cells with 
higher or lower protein expression as a means of assessing differentiation efficiency.  
MYOC is a robust marker for TM cells, but additional rigor was sought by testing 
other markers. Thus, protein-level detection was performed by flow cytometry on 
additional MSC and TM cell markers. Specifically, CHI3L1 (Gonzalez et al., 2006) and 
tPA (Stamer et al., 1995) are both established TM cell markers and were found to be 
expressed at higher levels in TM cells vs. MSCs. With the multiplex capabilities of flow 
cytometry, these two markers as well as MYOC could be characterized simultaneously, 
reducing sample size and increasing throughput. In addition to TM markers, we also 
studied known stem cell markers, so that loss of stem-phenotype could be monitored as 
cells were differentiating. Specifically, CD73 and CD90 were found to be expressed at 
higher levels in MSCs vs. TM cells, providing additional protein-level characterization 
points for further studies.   
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While protein and messenger-level changes can show evidence of TM-like 
phenotype, functional assays are also needed. We thus used a gel contraction assay to 
test for cell contractility, a characteristic property of the TM (Dismuke et al., 2014b). 
Alterations to TM permeability, and, thus, outflow resistance, are believed to be related 
to the cells’ contractile capabilities, making this a key functional parameter for TM cells 
(Llobet et al., 2003). Due to differences in the rate of proliferation between cell types and 
the impact that cell number has on gel contraction, collagen gels were created and 
remained in serum-free media for the entire assay. Contrary to our expectation, we 
consistently observed higher levels of contraction in MSC gels one hour after release 
and persisting through to steady state for all MSC and TM cell donor strains tested. 
While not normally thought of as contractile, MSCs share many functional characteristics 
with fibroblasts, a known contractile cell type, and have also been shown elsewhere to 
be contractile (MacQueen et al., 2013). Regardless, significant and robust contraction 
differences were found between TM cells and MSCs, providing a useful functional 
measure of cell phenotype.  
Like contractility, phagocytosis is a vital function for TM cells (Buller et al., 1990; 
Johnson et al., 1989; Sherwood and Richardson, 1988). Conversely, MSCs have not 
been reported to be phagocytic, making this parameter a possible further functional 
difference between cell types. Using pH-sensitive particles, confounding issues in 
regards to insufficient washing and particles sticking to the extracellular plasma 
membrane are avoided entirely since fluorescence outside the cell should remain 
minimal. After four-hour exposure, higher uptake was consistently seen in TM cells vs. 
MSCs. However, MSCs fluorescence was much greater than the unstained controls, 




Overall, the methods described here provide multiple approaches to quantify 
differentiation of MSCs to TM cells. RT-PCR allows for high-throughput analysis of 
multiple parameters simultaneously, useful in pilot experiments, and we have developed 
a panel of transcripts that will be useful in further TM differentiation studies. At the 
protein level, DEX induction of MYOC is essential to differentiation detection since this 
phenomenon is robust and unique to a TM-like phenotype. We recommend quantifying 
DEX induction using flow cytometry to allow for multiplexed assays of MYOC plus the 
other protein markers described herein. Finally, functional-level characterization should 
be considered in order to truly confirm differentiation to a TM-like phenotype. We 
specifically suggest that at least one functional parameter, either contractility or 
phagocytosis, should be used for this purpose. The results described herein will be 
valuable as glaucoma therapies based on differentiation of MSCs to a TM-like 
phenotype are developed. 
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CHAPTER 4.    An Ultrasound-Photoacoustic Imaging Platform 
for Visualizing Mesenchymal Stem Cell Delivery and Retention in 
the Trabecular Meshwork 
This chapter is a manuscript to be submitted to APL Bioengineering with the 
following author list: Kelsey Kubelick*, Eric J. Snider*, C. Ross Ethier, Stanislav 
Emelianov (*Denotes co-first author). The co-first authors were responsible for the 
following aspects of this work: 
• KK – performed electron microscopy experiments, all US-PA imaging as well as 
subsequent US-PA image analysis (unmixing, signal distribution, polar histograms) 
• EJS – maintained and prepared all cells for experiments, injected cells into eyes and 




Glaucoma is a major cause of blindness and is associated with elevated 
intraocular pressure. The trabecular meshwork (TM), the tissue that primarily regulates 
intraocular pressure, is known to have reduced cellularity and presumably reduced 
function in glaucoma. Thus, stem cells offer a novel therapeutic route for glaucoma if 
properly delivered to the TM. Mesenchymal stem cells (MSCs), which are readily 
isolated from adult tissue, have been delivered to the TM; however, MSC delivery 
efficiency, as determined by histology at single time points, has been inconsistent. To 
further study MSC delivery to the TM, improved imaging is needed to track cells non-
invasively. Here, we show that ultrasound and photoacoustic (US-PA) imaging has the 
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potential to monitor stem cell delivery to the TM, in real-time and longitudinally. Gold 
nanosphere-labeled MSCs (AuNS-MSCs) could be distinguished from background PA 
signals using spectroscopic PA imaging. AuNS-MSCs were tracked during delivery into 
the porcine anterior chamber and were also detectable 5 hours post-delivery after 
retention in anterior segment tissues. Furthermore, US-PA imaging was validated by 
comparison to fluorescent microscopy results. Overall, this study provides proof-of-
concept that US-PA imaging can assess MSC delivery in the anterior eye to monitor and 
improve cell-based therapies. 
4.2 Introduction 
Glaucoma, a leading cause of blindness, affects over 70 million people 
worldwide. Its incidence is expected to continue to rise as the population ages (Cook 
and Foster, 2012; Quigley and Broman, 2006). A well-established risk factor for 
glaucoma is elevated intraocular pressure (IOP), which is determined by aqueous humor 
production rate within the eye and the subsequent outflow of aqueous humor through 
drainage pathways in the anterior eye (Weinreb and Khaw, 2004). The primary aqueous 
humor drainage route, known as the conventional pathway, consists of the trabecular 
meshwork (TM), Schlemm’s canal, and, eventually, the circulatory system (Fautsch and 
Johnson, 2006; Goel et al., 2010). 
In glaucoma patients, the cellularity of the TM is reduced (Alvarado et al., 1984; 
Baleriola et al., 2008; Gonzalez et al., 2006; Liton et al., 2005).  The TM, along with the 
inner wall of Schlemm’s canal, is known to be the major site of outflow resistance.  In a 
healthy eye, TM cells phagocytose debris from the aqueous humor to prevent outflow 
blockage, contract to alter outflow resistance, and actively remodel their extracellular 
matrix to modulate tissue permeability (Bradley et al., 2003; Buller et al., 1990; De Groef 
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et al., 2013; Llobet et al., 2003; Sherwood and Richardson, 1988). Thus, reduced TM 
cellularity presumably leads to tissue dysfunction, increased outflow resistance, and 
subsequent elevated IOP. Therapies focused on restoring TM cellularity and function 
could thus offer a therapeutic benefit to glaucoma patients.  
Towards this end, regenerative medicine therapies are being developed for the 
glaucomatous TM. Multiple studies have focused on using fibroblast-derived induced 
pluripotent stem cells (iPSCs) to create functional TM-like cells (Abu-Hassan et al., 
2014b; Ding et al., 2014; Zhu et al., 2016a). While iPSCs were shown to be able to 
differentiate into a TM phenotype, challenges due to teratoma tumor formation in vivo 
and regulatory hurdles make clinical translation difficult for the use of pluripotent stem 
cells (Fong et al., 2010; Neofytou et al., 2015). Alternatively, adult-derived mesenchymal 
stem cells (MSCs) can be used. MSCs are commonly used in a clinical setting and are 
readily isolated from sites such as bone marrow or adipose tissue (Jin et al., 2013).  
While few studies to date have used MSCs for recellularizing the TM, two studies 
have investigated MSC delivery to the TM in vivo (Manuguerra-Gagne et al., 2013; 
Roubeix et al., 2015). Manuguerra-Gagne et al. demonstrated, in a laser-induced model 
of glaucoma in rats, that injected MSCs led to decreased IOP. However, only 11% of 
MSCs were found in the eye after 24 hours and no cells were found after 96 hours. 
Similarly, Roubeix et al. demonstrated, in an episcleral vein cauterization model of 
glaucoma in rats, that injected MSCs also reduced elevated IOP. Interestingly, MSCs 
were observed in many anterior tissues, including the TM, for at least 24 days. However, 
the majority of MSCs were found on the corneal endothelium, iris, and ciliary processes 
as opposed to the desired TM location.   
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While both studies demonstrate potential of MSCs for glaucoma treatment, 
delivery and retention of MSCs to the TM appears to be a challenge.  As is the case for 
nearly all cellular therapies, studies to date have used histological processing at set time 
points to evaluate MSC location and study outcomes.  Due to the invasive nature and 
tedious sample preparation of histology, it is impossible to monitor the same sample 
longitudinally.  Thus, a noninvasive imaging modality would greatly benefit development 
of stem cell therapies in the anterior eye by providing real-time, longitudinal information 
on cell delivery to target tissues.   
Ultrasound and photoacoustic (US-PA) imaging are excellent options for 
noninvasive, longitudinal stem cell tracking.  Ultrasound (US) imaging is based on 
scattering of high-frequency acoustic waves and has already been used to visualize 
changes in the anterior segment of glaucomatous eyes (Marchini et al., 1998; Nolan, 
2008; Pavlin et al., 1992; Sakuma et al., 1997; Thomas et al., 2014).  Because image 
contrast in ultrasound imaging depends on scattering, it is effective for depicting the 
overall anatomy of the anterior segment, but is poorly suited to distinguishing a specific 
signal of interest, such as the presence of stem cells.  Fortunately, photoacoustic (PA) 
imaging has the potential to supplement the anatomical information provided by 
ultrasound imaging.  In PA imaging, pulsed laser irradiation of optical absorbers leads to 
thermoelastic expansion of the surrounding tissue to produce a pressure wave that is 
detectable by an ultrasound transducer (Xu and Wang, 2006).  PA imaging has sub-
millimeter resolution, high contrast, and increased imaging depth compared to purely 
optical methods.  PA signal can be generated by endogenous tissue absorbers, such as 
melanin and hemoglobin, or exogenous absorbers, such as dyes and nanoparticles 
(Cook et al., 2011; Galanzha et al., 2009; Kim et al., 2009; Krumholz et al., 2014; Wang 
and Yao, 2016). Because PA imaging depends on optical absorption, the modality 
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directly compliments information from ultrasound, and is better suited to tracking a target 
of interest.  By using optical absorbers to label stem cells, US-PA imaging has been 
applied to assay stem cell delivery in other applications (Jokerst et al., 2012; Nam et al., 
2012; Ricles et al., 2014).  
Here, we have developed an US-PA imaging scheme for tracking labeled MSCs 
in the anterior segment of the eye.  We previously characterized endogenous PA signal 
in the porcine anterior segment (Kubelick et al., 2017, in preparation). Using this 
information, we hypothesized that gold nanospheres would be an effective contrast 
agent to distinguish labeled stem cells from endogenous absorbers in the anterior 
segment. Designing a detection protocol based on US/PA imaging for TM regenerative 
medicine will allow for non-invasive monitoring of stem cell delivery, simplifying 
optimization and expediting development of novel therapies for glaucoma treatment. 
4.3 Methods and Materials 
4.3.1 Mesenchymal Stem Cell Sourcing 
Human adipose derived MSCs (Lonza) were grown in α-minimum essential 
medium supplemented with 20% fetal bovine serum (FBS), penicillin, streptomycin, and 
L-glutamine. At 80-90% confluency, MSCs were detached using 0.05% Trypsin/EDTA 
and seeded in fresh cell-culture T75 flasks at a seeding density of 5,000 cells/cm2.  In all 
experiments, MSCs were used at passage numbers five or six. Each MSC donor strain 
was validated by Lonza for expression of MSC surface markers (CD13, CD29, CD44, 
CD73, CD90, CD105, and CD166) and minimal expression of negative MSC markers 
(CD14, CD 131, CD45). Each MSC donor strain was also previously characterized in our 
lab for adipogenic, chondrogenic, and osteogenic differentiation as well as CD90 
expression following expansion (Snider et al., 2017). 
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4.3.2 Gold Nanotracer Synthesis  
Hydrogen tetrachloroaurate (III) hydrate (HAuCl4 x H2O, Alfa Aesar) and sodium 
citrate tribasic dihydrate (HOC(COONa)(CH2COONa)2 x 2H2O) Sigma Aldrich), were 
used as received.  Gold nanospheres (AuNS), 20nm diameter, were synthesized via the 
citrate reduction method (Kimling et al., 2006; Turkevich, 1985; Turkevich et al., 1951).  
Briefly, 0.5ml of a 1% w/v solution of hydrogen tetrachloroaurate was added to 47ml of 
deionized ultrafiltered water. The solution was brought to a boil while stirring, then 2.5ml 
of a 1% w/v solution of sodium citrate was added.  After approximately 15 minutes, the 
solution appeared red and was cooled to room temperature.  UV-Vis spectrophotometry 
(Synergy HT microplate reader, BioTek Instruments) between 400nm to 995nm was 
used to validate the absorbance spectra and optical density of the particles.  
Transmission electron microscopy (TEM) (Hitachi HT7700 TEM, IEN/IMAT Materials 
Characterization Facility, Georgia Institute of Technology) was used to validate particle 
size and morphology.  AuNSs were sterilized under UV light for at least 12 hours prior to 
stem cell labeling experiments. 
4.3.3 AuNS and CFSE Stem Cell Labeling 
Gold nanoparticles were incubated for 24 hours with adipose derived MSCs 
(Lonza) at an optical density of 2, a measure of concentration according to light 
absorbance, in alpha-minimum essential medium (Mediatech) supplemented with 20% 
fetal bovine serum, 2mM L-glutamine, and 1x penicillin/streptomycin. AuNS were 
previously determined to have minimal cytotoxic effects on stem cells (Ricles et al., 
2011).  Following uptake, gold nanosphere-labeled stem cells (hereinafter referred to as 
AuNS-MSCs) were collected and used for cell tracking experiments.  AuNS-MSCs were 
washed with PBS to remove excess nanoparticles, detached with Trypsin-EDTA, and 
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centrifuged (300 x g, 10 minutes) to separate free AuNS from AuNS-MSCs. For 
fluorescent cell detection, MSCs were also labeled with 5µM carboxyfluorescein 
succinimidyl ester (CFSE, Affymetrix) for fifteen minutes at 37oC, followed by washing 
with cell culture media to remove excess CFSE. 
We used a Vevo 2100 imaging system, incorporating ultrasound and 
photoacoustic (US/PA) imaging modalities (VisualSonics, Inc., see section 4.3.6 for 
further details), to verify that AuNS-MSCs were labeled and produced a photoacoustic 
signal.  AuNS-MSCs were imaged in a tissue-mimicking gelatin phantom (Cook et al., 
2011).  The base of the phantom consisted of 8% (w/v) gelatin and 0.2% (w/v) silica 
(Sigma-Aldrich). Inclusions were made by adding 16% (w/v) gelatin to an equal volume 
of AuNS-MSCs.  Each inclusion was imaged over a range of wavelengths (λ=680 nm to 
970 nm at 5nm increments), with the US/PA transducer oriented perpendicular to the 
gelatin base. 
4.3.4 Stem Cell Delivery in ex vivo Experiments 
For ocular delivery experiments, porcine eyes from a slaughterhouse (Holifield 
Farms, Covington, GA) were used within 3 to 4 hours of enucleation. To maintain 
physiological pressures during cell injection, a reservoir containing serum-free, phenol 
red-free DMEM (supplemented with 1x penicillin, 1x streptomycin, 1x amphotericin, and 
2mM L-glutamine) was connected to each eye by cannulating the anterior chamber 
using a 23-gauge needle passing through the cornea. Reservoirs were placed 10 to 16 
cm above the limbus (cornea-sclera transition region) to clamp intraocular pressure 
(IOP) at 8 to 12 mmHg. 250 µL of a solution containing AuNS-MSCs was injected into 
the anterior chamber through the central cornea using a 27-gauge needle. We used a 
variety of cell concentrations so that either 250,000, 500,000 or 1,000,000 (250k, 500k, 
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and 1000k, respectively) AuNS-MSCs were delivered into the eye. After injection, eyes 
remained pressure clamped at 8 to 12 mmHg, and were stored in a cell culture incubator 
for 5 hours.  At five hours post-injection, eyes were perfused with 10% formalin overnight 
at 8 to 12 mmHg IOP, followed by submersion in 10% formalin overnight to fully fix eyes. 
Some eyes were US-PA imaged for 15 minutes following AuNS-MSC injection as 
indicated. All eyes (n=3 for each cell concentration) were US-PA imaged after fixation to 
assess AuNS-MSC delivery.   
4.3.5 Anterior Segment Dissection 
Fixed eyes were dissected to isolate the anterior segment, similar to previously 
reported methods (Bachmann et al., 2006; Bhattacharya et al., 2009). Briefly, orbital 
connective tissue was dissected away, and eyes were hemisected with a razor blade to 
isolate the front half of the eye. The vitreous humor and lens were removed, the iris was 
cut radially back to the iris root and pectinate ligaments until the TM was revealed, and 
the ciliary processes were carefully removed while preserving the TM. Any remaining 
vascularized or pigmented tissue was removed. Dissected anterior segments (n=4 for 
each concentration) were again US-PA imaged to confirm TM delivery, as described 
below.  
4.3.6 Ultrasound-Photoacoustic Imaging of Porcine Eyes 
The Vevo 2100 (VisualSonics) combined ultrasound and photoacoustic (US/PA) 
imaging system was used for all US/PA imaging.  US/PA images were acquired using 20 
MHz (LZ250/LZ550), 256 element transducers at a frame rate of 5Hz with an OPO, Q-
switched Nd:YAG laser (λ=680-970nm, PRF=20Hz, 7ns pulse duration).  Built-in 
software was used to calibrate laser energy across all wavelengths at the time of 
acquisition.  A translational motor was used to acquire spatial 3D images as required. 
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Eyes or dissected anterior segments were secured on top of a tissue-mimicking 
phantom composed of 1% (w/v) agarose and fully submerged in PBS for imaging.  All 
eyes were imaged with the transducer centered over the cornea, perpendicular to the 
surface of the tissue-mimicking phantom.  During cell injections, US/PA images were 
continuously acquired at λ=700nm due to the high absorption of AuNS-MSCs and laser 
stability at that wavelength.  Following injection, 2D US/PA images were acquired 
approximately every 3 minutes for 15 minutes from λ=680 to 970nm in 5nm increments, 
and again at 5 hours post injection.  3D spectroscopic images were also acquired at 5 
hours post injection in whole eyes and dissected eyes.  Due to hardware limitations, 3-
dimensional images could only be acquired at a subset of wavelengths, and preliminary 
studies (data not shown) showed that imaging with λ=680nm to 710nm at 10nm 
increments produced PA signals from labelled cells that could be effectively separated 
from background signal.   
4.3.7 Fluorescence Microscopy 
Following US-PA imaging of dissected eyes, scleral tissue posterior to the TM 
was removed to improve imaging, and dissected anterior segments were placed in PBS 
on a 50mm glass-bottomed dish so that the TM was in direct contact with the dish 
surface. Micrographs of the entire TM circumference were captured by confocal 
microscopy (LSM 700, Carl-Zeiss) to identify delivered CFSE-tagged MSCs in the TM 
region. Brightfield overlays were also captured to identify the corneal margin and hence 
the approximate location of the TM. Micrographs were captured as z-stacks of tile scans 
at 50x to account for TM depth and height differences in the tissue. Maximum intensity 
projections were created for each en face image for use in further image quantification.  
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4.3.8 Image Analysis 
4.3.8.1 US-PA Image Processing 
Spectroscopic PA images were unmixed at each pixel using Equation 1: 
𝑃 = ᴦ 𝜇𝑎𝐹 = 𝑘𝜇𝑎 = 𝑘 ∑ 𝐶𝑖
𝑛
𝑖=1
𝜎𝑎𝑖                                               (1) 
where P describes the measured PA signal in terms of pressure on the surrounding 
tissue; F is light fluence at the location of the absorber; and ᴦ is the Grüneisen 
parameter, a tissue-dependent efficiency factor describing conversion of light to 
pressure.  The equation is simplified by treating the product of the fluence and the 
Grüneisen parameter as a constant, k.  The optical absorption coefficient, 𝜇𝑎, depends 
on wavelength and is the product of the concentration of the absorber, C, and the optical 
cross sections of that absorber, 𝜎𝑎, relative to its maximum (Luke et al., 2013).  𝜎𝑎 was 
previously determined by spectroscopic PA analysis of endogenous anterior segment 
absorbers (Kubelick et al., 2017, in preparation) and AuNS-MSCs in vitro. In our case, 
we assumed that the photoacoustic signal at each pixel was the sum of contributions 
from melanin and AuNS-MSCs, i.e. n=2.  Thus, solving for Ci produced a map of 
unmixed amplitudes associated with each PA absorber with dimensions (depth x width x 
number of absorbers).  Solutions for Ci were restricted to positive values.  
Images were post-processed using MATLAB.  Prior to spectroscopic unmixing, 
PA images were spatially filtered using a 3 x 3 pixel (41µm x 45µm) median filter to 
remove speckle and large noise fluctuations.  In the case of 2-dimensional spatial 
images, images were low pass filtered using a 6 pixel x 9 pixel x 3 frame moving 
average filter, approximately corresponding to 252µm x 405µm, three times the axial and 
lateral resolution, and a wavelength range of λ=15nm.  In the case of 3-dimensional 
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spatial images, images were low pass filtered using only a 6 pixel x 9 pixel x 3 slice 
moving average filter, i.e. images were only spatially filtered.  Signals below the 
threshold defined in Equation 2 were eliminated: 
Threshold = Pminimum + 2.5% (Pmaximum – Pminimum)              (2) 
For dissected eyes, the 3-dimensional matrix of the unmixed PA signal from cells 
was integrated across the image depth to produce a 2-dimensional map of AuNS-MSC 
distribution around the circumference of the eye.  The TM region was specifically 
isolated for analysis by producing a ring mask using anatomical landmarks.  However, 
due to differences in imaging modalities, different anatomical landmarks were used for 
each imaging modality. For PA image analysis, the endogenous PA signal from melanin 
was used to define the inner (cornea-side, or anterior-most) margin of the TM. The outer 
(posterior-most) margin of the TM was then defined as 1mm posterior to the inner 
margin.      
For fluorescent image analysis, images were filtered to eliminate noise spikes 
using the same median filter as used for PA images.  The low pass filter was applied by 
spatially matching the largest dimension of the PA low pass filter, namely 400 µm. To 
isolate the TM region, the corneal margin was determined from the brightfield image, 
and the TM was defined as a 1mm wide band adjacent to this margin to match the 
photoacoustic image processing technique.   
A polar coordinate system centered on the cornea was overlaid on all images 
and polar histograms were produced by integrating unmixed PA and fluorescent 
intensities from cells over 15o wedges. Since the photoacoustic and fluorescent images 
were taken at different times, small notches were cut in the sclera of each eye to act as 
landmarks and thus provide approximate image orientation for subsequent alignment. 
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Notches were positioned at similar cardinal points during image acquisition for both 
modalities.  
Fluorescent signal was summed around the entire 360o TM region for each 
fluorescent and photoacoustic image to assess agreement between each imaging 
modality. Signal from fluorescent images was not normalized for this analysis, while 
signal from PA images, due to fluctuations in laser power, was normalized to average 
PA signal from the PBS in which eyes were immersed. Signal from no cell, 250k, 500k, 
and 1000k AuNS-MSC injected eyes were compared using scatter plots of fluorescent 
signal vs. PA signal.  
Statistics 
For each MSC injected cell number (250k, 500k, and 1000k cells), n = 3 eyes 
were studied by US-PA imaging and fluorescent microscopy. For assessing correlations 
between imaging modalities, a Pearson correlation coefficient was calculated for each 
data set, with p < 0.05 denoting statistical significance as determined by Student’s t-
distribution.  
4.4 Results 
4.4.1 Labeling MSCs with AuNS and Their Corresponding Spectra 
AuNS were approximately 20 nm in diameter, as determined by TEM (Figure 
11A). After incubating MSCs with AuNS at a concentration of 2 OD for 24 hours to allow 
cellular uptake of the nanoparticles, there was noticeable particle accumulation in the 
cytoplasm, as detected by light microscopy (Figure 11B, C). As expected, AuNS alone 
produced minimal photoacoustic signal at =700nm, since the absorption peak of the 
nanospheres is at =532nm (Figure 11D). Unlabeled MSCs were detected by ultrasound 
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but produced no PA signal (Figure 11E).  However, AuNS-MSCs produced a PA signal 
at =700nm due to surface plasmon resonance coupling of nanoparticles that had been 
uptaken, as previously reported in other studies (Nam et al., 2012) (Figure 11F).  This 
was consistent with light microscopy, showing successful labelling of MSCs with AuNS.   
The PA spectrum of AuNS-MSCs from = 680 to 970nm was compared to 
measured PA spectra of melanin, expected to be the main endogenous absorber in 
porcine ocular tissue (Figure 11G). The PA spectral signature of AuNS-MSCs was 
distinct from melanin, opening the possibility for distinguishing AuNS-MSC signal from 
background in the eye. Overall, we conclude that AuNS particles can label MSCs, and 
that the distinct PA spectra of AuNS-MSCs is conducive to cell tracking in the porcine 
anterior segment using spectroscopic imaging.   
 
Figure 11. AuNS Labeling of MSCs and Resulting PA Properties. (A) TEM of AuNS 
showing uniformity and approximate particle size. (B, C) Brightfield micrograph of MSCs 
following AuNS incubation at 2OD for 24 hours. AuNSs are evident (arrowheads) around 
hematoxylin stained nuclei. (D - F) US-PA signal at 700 nm wavelength from gelatin 
phantoms for (D) AuNS only, (E) unlabeled MSCs, and (F) AuNS-MSCs. In panels D - F, 
the top row shows US signal only, the middle row shows the PA signal only, and the 
bottom row shows the merge. In panel D, the faint PA signal was due to trapped air 
bubbles in the gelatin inclusion, which were also evident by US imaging. (G) PA spectra 
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for AuNS-MSCs compared to melanin, thought to be the main endogenous absorber in 
the porcine eye.  
4.4.2 US-PA Imaging of AuNS-MSC Injections into the Anterior Segment 
AuNS-MSCs were fluorescently tagged with CFSE and resuspended at 1 million 
cells/mL in media. While the eye was pressure clamped, 250µL of the MSC-containing 
solution was injected into the anterior chamber.  PA images were acquired at =680 to 
970nm. US-PA imaging occurred before, during, and for up to fifteen minutes after the 
cell injection.   
Prior to injection, PA signal due to melanin was visible at the trabecular 
meshwork (TM) and iris, with additional signal at the site of the injection needle (Figure 
12A) at =700nm.  MSCs could be visualized by both ultrasound and PA imaging 
immediately after injection, confirming successful delivery into the anterior chamber 
(Figure 12B).  However, when using only a single PA wavelength (700nm), AuNS-MSCs 
were difficult to detect at 9 minutes post-injection (Figure 12C), and seemed to have 
completely disappeared at 15 minutes post-injection (Figure 12D).  We hypothesized 
that cells may have simply moved out of the plane of view, or may have traveled to 
surrounding tissues, where strong absorption from melanin at the iris and TM may have 
overpowered PA signal from AuNS-MSCs, making it impossible to visualize AuNS-MSCs 
with only a single imaging wavelength.  Therefore, we carried out spectroscopic PA 
imaging with unmixing to accurately localize absorbers by detection of distinct spectral 
signatures of AuNS-MSCs and endogenous absorbers (Figure 12E-L).  Prior to AuNS-
MSC injection, spectroscopic unmixing accurately localized background signals (Figure 
12E), with no AuNS-MSCs being detected (Figure 12F), as expected.  Immediately after 
injection, PA signals from melanin remained separate from AuNS-MSCs (Figure 12F), 
with AuNS-MSCs being localized to the aqueous humor (Figure 12J).  AuNS-MSCs 
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could still be visualized at 9 and 15 minutes post-injection using spectroscopic unmixing 
(Figure 12K, L) showing improved detection compared to single-wavelength PA imaging.  
 
Figure 12. Spectroscopic Photoacoustic Imaging of AuNS-MSCs Following 
Delivery to the Anterior Chamber. Photoacoustic images (color scale) were analyzed 
before injection, and then immediately, nine, and fifteen minutes after injection (columns 
left to right).  (A-D) Shows single PA wavelength imaging at 700nm, while (E-L) show 
spectroscopic photoacoustic imaging. (E-H) Image pixels classified as endogenous 
absorbers, primarily melanin-containing ocular tissues. (I-L) Image pixels classified as 
AuNS-MSCs. Scale bar= 3mm.  
4.4.3 Detection of AuNS-MSCs in TM, 5 hours Post-Delivery 
Eyes were fixed 5 hours after AuNS-MSC delivery, and US-PA imaging was 
performed to assess the presence of AuNS-MSCs in the anterior segment. Eyes were 
injected with media-only (control eye; Figure 13 A, B), 250k (Figure 13 C, D), 500k 
(Figure 13 E, F), or 1000k AuNS-MSCs (Figure 13 G, H) in 250µL to determine if US-PA 
imaging was able to detect differences related to cell concentration. In the control eye, 
spectroscopic PA unmixing correctly identified endogenous background absorbers 
(Figure 13 A, B), indicating that melanin could be detected and isolated.  Increased 
AuNS-MSC PA signal was qualitatively observed as the number of injected cells 
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increased (Figure 13 D, F, H).  In the 250k cell eye, AuNS-MSCs were largely confined 
to the anterior surface of the lens (Figure 13D).  As the injected cell number increased to 
500k (Figure 13F) or 1000k (Figure 134H), cell signal extended to the anterior iris, and 
was even evident further into the anterior angle, indicative of some TM delivery.  
However, these images were for only a single sagittal plane through the anterior 
segment, and thus did not give a complete understanding of injected cell distributions in 
the anterior segment. We therefore created 3D images (Figure 13 I, J), which were 
generally consistent with 2D images. For example, greater AuNS-MSC signal was 
clearly observed when 1000k cells were injected (Figure 13 J) vs. in control eyes (Figure 
13 I). Segmental, non-uniform delivery was evident from 3D views, i.e. cell signal was 
more concentrated in some regions while others contained minimal signal (Figure 13 J).  
Overall, spectroscopic PA imaging successfully separated PA signals from melanin-
containing tissues from that of labelled cells. AuNS-MSCs were detected in anterior 
segment tissues up to 5 hours post-injection.  Further as the number of injected cells 
increased, cells were more widely spread and the amplitude of unmixed PA signal on the 







Figure 13. Ultrasound-Spectroscopic Photoacoustic (US-PA) Imaging Detects 
AuNS-MSCs Five Hours After Injection. Overlay of ultrasound (gray) and 
spectroscopic photoacoustic (color scale) images in single planes (A-H).  Each column 
separates photoacoustic signals according to melanin (left; “background”) and AuNS-
MSCs (right).  Each row corresponds to different concentration of cell injection: (A,B) 
control, no cells, (C,D) 250,000 cells , (E,F) 500,000 cells, (G,H) 1,000,000 cells. 3D 
views of the anterior segment of each eye were also captured (I,J) to better show cell 
location around the entire TM circumference. (I) shows an eye with only vehicle (no 
cells) injected, while (J) shows a 1 million cell injection, both 5 hours after injection. 
Signal on the posterior sclera was due to signal spillover from regions of high PA signal.  
Yellow-pink color scale = labeled MSCs.  Green-blue color scale = melanin.  Scale bar = 
3mm 
4.4.4 Assessment of MSC delivery to the TM 
Eyes were dissected to isolate the anterior corneoscleral shell and thus 
specifically assess MSC delivery to the trabecular meshwork. These dissected ocular 
shells were imaged en face using fluorescence microscopy (Figure 14, Columns 1 and 
2) and spectroscopic PA imaging (Figure 14, Column 4) to benchmark PA imaging 
against a more established method, namely fluorescence microscopy.  
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After selecting the TM region, fluorescent micrographs (Figure 14 A – C) were 
filtered similarly to photoacoustic images and shown as heat maps of AuNS-MSC signal 
intensity (Figure 14 D – E) for comparison to PA signal intensity (Figure 14 J – L).  Heat 
maps were further used to create polar histograms of relative cell density to more easily 
visualize and compare cell distribution patterns (Figure 14 F – G and M - O). Fluorescent 
and PA signal distributions were similar for the 500k cell injection, and some regions in 
the 250k injection showed consistent signal between the two imaging modalities. 
However, on balance, the AuNS-MSC signal from PA images did not correlate 
particularly well with the fluorescent signal. Differences were most pronounced at the 
1000k injections, where higher AuNS-MSC signal was evident by fluorescence imaging 
vs. PA signal.  
 
Figure 14.  Spectroscopic PA and Fluorescent Microscopy Images of Labeled 
MSCs with Additional Processing to Isolate the TM. Each row shows one 
representative sample imaged with both modalities, with the top, middle and bottom 
rows corresponding to injection of 250k, 500k, or 1000k AuNS-MSCs, respectively.  
Each column depicts, in order from left to right: (A, F, K) the fluorescent signal masked 
to show only the TM region; (B, G, L) a filtered heat map version of the fluorescent 
signal relative to maximum signal intensity; (C, H, M) the corresponding polar histogram; 
(D, I, N) the heat map for PA signal after masking to isolate the TM and filtering; and (E, 




4.4.5 Correlation of MSC Distribution Between US-PA and Fluorescent Images 
We next quantified the overall agreement between AuNS-MSC signal as 
determined from US-PA and fluorescent images. The US-PA and fluorescent signal 
intensities in the TM region were summed over the entire 360o circumference of the 
eyes. We cross-plotted the fluorescent signal against the PA signal in the corresponding 
eye and performed a linear least-squares regression to determine whether a correlation 
existed between these two signals (Figure 15).  
First, comparing only no cell and 250k (n=3 for each) images, a strong, 
significant correlation was found (R2 = 0.87, Figure 15A). Second, adding in 500k 
images (n=3), the R2 value was decreased to 0.70 but the correlation was still significant 
(Figure 15B). Lastly, when the 1000k images (n=3) were incorporated, US-PA and 
fluorescent were no longer in agreement, as evident by the low R2 value (Figure 15C). It 
was clear that lack of correlation between the two imaging modalities only occurred 
when large numbers of AuNS-MSCs were delivered into the TM.  
 
Figure 15. Comparison between US-PA and fluorescent imaging modalities for 
AuNS-MSC signal in the TM region. (A – C) Scatterplots of photoacoustic signal vs. 
fluorescent signal arising from AuNS-MSCs.  Each data point represents the total signal 
in the entire TM region. Plots show the different cell injection amounts: (A) 250k and no 
cell, (B) 500k, 250k, and no cell, and (C) 1000k, 500k, 250k, and no cell (n = 3 for each 
 61 
 
group). Significant linear correlations (p < 0.05) were observed for each plot as 
determined by student’s t-distribution.  
4.5 Discussion 
MSCs have the potential to treat ocular hypertension, i.e. TM dysfunction, in 
glaucoma patients. Clinical translation of such an approach will require MSCs to be 
efficiently delivered to the TM. Previous studies in which cells were injected into the 
anterior chamber and then passively carried to the TM by aqueous humor outflow 
showed that stem cells were undetectable in the TM after only 4 days, or showed 
significant stem cell delivery to unwanted sites, such as the cornea and iris 
(Manuguerra-Gagne et al., 2013; Roubeix et al., 2015). This suggests that MSC delivery 
in the anterior eye is a complex process. 
Understanding the factors controlling stem cell delivery is made more challenging 
by the fact that delivery can currently only be assessed by histologic preparations at 
single, set time points. Thus, development of new stem cell-based therapies for ocular 
hypertension would greatly benefit from improved imaging to assess stem cell delivery 
longitudinally. One possible option, US-PA imaging, offers the possibility of non-invasive, 
non-destructive, longitudinal imaging of the same sample, which is simply not possible 
with standard histology and fluorescent microscopy. Here, we demonstrate the potential 
of US-PA imaging to track MSCs in the anterior segment. 
The movement of injected AuNS-MSCs due to gravity and fluid flow in the 
anterior chamber could be visualized by single wavelength US-PA imaging during MSC 
delivery into the anterior chamber and for the first 15 minutes after injection. However, 
within fifteen minutes after injection, the PA signal of AuNS-MSCs became too low to 
detect, relative to high background signals from melanin-containing tissues in the 
anterior segment. AuNS-MSCs may have moved out of view in the anterior chamber, 
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collected on tissue surfaces, reached the TM, or leaked out of the injection site.  
However, tracking AuNS-MSC delivery immediately after injection showed cells falling 
towards the lens, suggesting passive flow of aqueous humor is not sufficient for efficient 
delivery of cells to the TM.  
We therefore turned to spectroscopic photoacoustic (sPA) imaging to distinguish 
AuNS-MSCs from endogenous absorbers. By using spectral sweeps, the unique 
spectral signatures of AuNS-MSCs and of melanin allowed the PA signals from these 
two sources to be separated, which improved the detection of AuNS-MSCs after they 
traveled to melanin-rich regions.  This signal separation (unmixing) approach proved to 
be feasible in all eyes tested, suggesting it is a robust approach. However, this still 
needs to be assessed before transitioning to in vivo experiment due to hemoglobin from 
blood in the anterior segment, another endogenous absorber.  
Five hours after MSC injection into the anterior chamber, sPA imaging was able 
to detect MSCs in the anterior segment. As the initial 15-minute delivery results 
suggested, most MSCs had settled under gravity onto tissue surfaces, primarily the 
anterior surfaces of the iris and lens. Further, sPA imaging could be used to acquire 3D 
images of the entire anterior segment, which allowed for non-invasive monitoring of MSC 
delivery and the distribution of MSCs. Specifically, these images showed extensive 
coating of the lens by MSCs, while the iris was only coated in certain regions, suggesting 
segmental outflow. MSCs engrafting onto or into the lens could lead to loss of lenticular 
optical clarity and reduced vision, a serious complication of stem cell therapy. These 
results demonstrate the utility of sPA imaging for monitoring and optimizing stem cell 
delivery to the TM.   
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A common approach for assessing cell delivery in pre-clinical trials is 
fluorescence microscopy of labelled cells. Disappointingly, US-PA and fluorescent 
imaging resulted in generally poor AuNS-MSCs signal distributions in the TM, with 
dissimilar trends between the two imaging modalities. We need to identify and reduce 
the sources of this discrepancy before US-PA imaging is used in actual regenerative 
medicine experiments. One possible source of discrepancy is improper registration of 
eye orientations between the two imaging modalities. Another possible source is 
uncertainty in selecting the TM region. In fluorescent imaging, the corneal margin was 
used as a landmark for selecting the TM, while PA imaging utilized the melanin signal 
associated with the TM. Since different anatomical landmarks were used, TM selection 
may not have been consistent, which would lead to variation.  
In whole eyes, US-PA imaging of the TM would require signals to pass through 
the sclera or cornea, whereas we carried out US-PA imaging of the TM on dissected 
anterior segments in which no intervening tissue was present. We adopted this approach 
because it was the only viable option for fluorescent microscopy, due to limitations of 
light penetration into tissue.  This approach thus represents a “best case” for US-PA 
imaging, since photons were not attenuated by the sclera or redirected away from the 
TM towards the lens by the cornea, as would occur when the exciting light was delivered 
from outside the eye. In a clinical setting, care would need to be taken to optimally target 
light to the TM. One approach would be to use a gonio lens, which refracts light toward 
the iridocorneal angle and which is routinely used for laser trabeculoplasty and 
visualization of angle structures in the clinic (Barkana and Belkin, 2007; Ho et al., 2009; 
Masihzadeh et al., 2013). With proper light delivery to the TM by developing a custom 
system or adopting clinically used technologies, longitudinal, non-invasive imaging for 
US-PA imaging is a real possibility.  
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In order to track delivery, MSCs were labeled with AuNS, since they are known to 
be efficient absorbers for PA imaging. While AuNS do not affect MSC viability and 
function (Ricles et al., 2011), they are known to accumulate heavily in the kidneys 
following AuNS intravenous injection in vivo, resulting in nephrotoxicity (Aillon et al., 
2009; Boisselier and Astruc, 2009; Khlebtsov and Dykman, 2011). This is less of a 
concern when using a relatively small number of nanoparticle-labeled cells, since the 
total AuNS burden would be lower than following a systemic injection. Nonetheless, 
AuNS toxicity is still a possible limitation that needs to be monitored as this work is 
translated to in vivo experiments. Ideally, the PA imaging approach presented herein 
would be clinically translatable for longitudinal monitoring of stem cell therapies as a 
routine part of the therapy. If this is not possible, for example due to toxic side-effects, 
US-PA imaging can still provide a valuable pre-clinical research platform for 
understanding and optimizing stem cell delivery to the TM.   
These initial experiments have highlighted an additional challenge for TM 
regenerative medicine, namely inefficient delivery of AuNS-MSCs to the TM and non-
specific delivery to other anterior segment tissues.  To improve TM delivery, we recently 
began investigating Prussian blue nanocubes (PBNCs), exogenous PA absorbers with 
an iron oxide core, that allow MSCs to be magnetically steered to the TM with good 
efficiency and specificity (Snider et al., 2018).  Our US-PA imaging results can be 
combined with these magnetic particles to improve delivery efficiency towards the TM. 
4.6 Conclusions 
US-PA imaging has the potential to image delivery of suitably-labelled stem cells 
to the TM non-invasively and in real time. Specifically, by using spectroscopic PA 
imaging, AuNS-MSCs were distinguishable from background PA signals from melanin-
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containing tissues up to 5 hours post-delivery. Further, US-PA imaging was generally 
consistent with MSC distributions obtained by conventional fluorescent microscopy.  
Next steps include implementing an improved light delivery setup to facilitate in vivo 
imaging, and longitudinal studies to confirm that US-PA imaging can track MSCs in the 
TM over multiple weeks.  
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CHAPTER 5.   Improving Mesenchymal Stem Cell Delivery to 
the Trabecular Meshwork Using Magnetic Nanoparticles 
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Glaucoma is a major cause of blindness and is associated with elevated 
intraocular pressure. The trabecular meshwork (TM), the tissue that primarily regulates 
intraocular pressure, is known to have reduced cellularity in glaucoma. Thus, stem cells 
offer a novel therapeutic route for glaucoma if properly delivered to the TM. For this 
purpose, targeted delivery of stem cells to the TM is desired. Here, we used magnetic 
nanoparticles (Prussian blue nanocubes [PBNCs]) to label mesenchymal stem cells and 
to magnetically steer them to the TM following injection into the eye’s anterior chamber. 
PBNC-labeled stem cells showed increased delivery to the TM vs. unlabeled cells after 
as little as a 15-minute exposure to a magnetic field. Further, PBNC-labeled 
mesenchymal stem cells could be delivered to the entire circumference of the TM, which 
was not possible without magnetic steering. PBNCs did not affect MSc viability or 
multipotency. We conclude that this labeling approach allows for a targeted, relatively 
high efficiency delivery of stem cells to the trabecular meshwork in clinically translatable 
time-scales, which are necessary steps towards regenerative medicine therapies for 




Glaucoma is a leading cause of blindness, affecting over 70 million people 
worldwide. Its incidence is expected to continue to rise as the population ages (Cook 
and Foster, 2012; Quigley and Broman, 2006). The best-established risk factor for 
glaucoma is elevated intraocular pressure (IOP), which is determined by the rate of 
aqueous humor production within the eye and the subsequent outflow of aqueous humor 
through drainage pathways in the anterior eye (Weinreb and Khaw, 2004). The primary 
aqueous humor drainage route is known as the conventional pathway, consisting of the 
trabecular meshwork (TM), Schlemm’s canal, and, eventually, the circulatory system 
(Fautsch and Johnson, 2006; Goel et al., 2010).  
In glaucoma patients, the cellularity of the TM is reduced (Alvarado et al., 1984; 
Baleriola et al., 2008; Gonzalez et al., 2006; Liton et al., 2005).  The TM, along with the 
inner wall of Schlemm’s canal, is known to be the major site of outflow resistance. 
Further, TM cells phagocytose debris from aqueous humor to prevent outflow blockage 
and are contractile, which can change outflow resistance (Buller et al., 1990; Llobet et 
al., 2003; Sherwood and Richardson, 1988). Thus, reduced TM cellularity presumably 
leads to tissue dysfunction and subsequent increased outflow resistance and elevated 
IOP. Therapies focused on restoring TM cellularity and function could therefore offer a 
therapeutic benefit to glaucoma patients.  
Towards this end, regenerative medicine therapies are being developed for the 
glaucomatous TM. Most existing studies have used fibroblast-derived induced 
pluripotent stem cells (iPSCs) or mesenchymal stem cells (MSCs) (Abu-Hassan et al., 
2014b; Ding et al., 2014; Manuguerra-Gagne et al., 2013; Roubeix et al., 2015; Zhu et 
al., 2016a). While each of these studies show the potential for regenerating the TM, 
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delivery of cells after injection into the anterior chamber has relied on the stem cells 
being passively carried by aqueous humor outflow to the TM. Passive delivery of stem 
cells has led to inconsistent MSC delivery to the TM and non-specific delivery to other 
anterior ocular tissues (Manuguerra-Gagne et al., 2013; Roubeix et al., 2015). Cell 
delivery to sites other than the TM is undesirable since stem cells may differentiate to 
undesired phenotypes in tissues such as the lens or cornea. 
Passive delivery is further complicated by aqueous humor outflow dynamics. 
Outflow from the TM is known to be non-uniform (segmental) around the TM 
circumference (Swaminathan et al., 2014). Indeed, studies indicate that as little as one-
third of the TM is actively filtering at any one time (Chang et al., 2014), suggesting that 
passively delivered stem cells could integrate into as little as one-third of the TM. Such 
an outcome is presumably sub-optimal, since active filtering regions may change over 
time. Further, outflow is more segmental in glaucomatous patients than in unaffected 
individuals (de Kater et al., 1989), so that this problem is even worse in the target patient 
population.  
To improve on conventional (passive) delivery, we propose to use magnetic 
nanoparticles to label MSCs and to then steer them to the TM using a magnetic field. 
Superparamagnetic iron oxide nanoparticles (SPIONs) have previously been used for 
targeted cell delivery to the retina (Ito et al., 2005; Yanai et al., 2012). For this study, we 
use Prussian blue nanocubes (PBNCs), which combine Prussian blue pigment with 
SPIONs (Cook, 2017).  The SPION core gives PBNCs magnetic properties that allow 
magnetic steering, while the Prussian blue pigment makes the particles strong absorbers 
of near-infrared light. We recently demonstrated that ultrasound-photoacoustic non-
invasive imaging can visualize anterior segment tissues, as well as the delivery of cells 
labelled with PBNCs (Kubelick et al., 2017, in preparation). Here, we ask the question as 
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to whether PBNCs are suitable for MSC labeling and can improve MSC delivery to the 
TM.  
5.2 Methods and Materials 
5.2.1 Mesenchymal Stem Cell Sourcing 
Human adipose derived mesenchymal stem cells (MSCs, Lonza) were grown in 
α-minimum essential medium supplemented with 20% fetal bovine serum (FBS), 
penicillin, streptomycin, and L-glutamine. At 80-90% confluency, MSCs were detached 
using 0.05% Trypsin-EDTA (w/v, Cellgro, Corning) and seeded in fresh cell-culture T75 
flasks at a seeding density of 5,000 cells/cm2.  In all experiments, MSCs were used at 
passage numbers five or six. Each MSC donor strain was validated by Lonza for 
expression of MSC surface markers (CD13, CD29, CD44, CD73, CD90, CD105, and 
CD166) and minimal expression of negative MSC markers (CD14, CD 131, CD45). We 
also previously characterized each MSC donor strain for adipogenic, chondrogenic, and 
osteogenic differentiation and CD90 expression following expansion (Snider et al., 
2017). 
5.2.2 PBNC Nanoparticle Synthesis and Characterization  
PBNCs were synthesized according to methods described previously  (Cook, 
2017). 150 mL of 0.04% (w/v) dextran-coated iron oxide (Fe3O4) nanoparticles (Ocean 
NanoTech) in deionized ultra-filtered water were vigorously mixed with 5 mL of 5% w/v 
potassium hexacyanoferrate(II) trihydrate (K4Fe(CN)6·3H2O, Sigma-Aldrich). After one 
minute, 2.496 mL of 1.85% (v/v) hydrochloric acid (HCl, Sigma-Aldrich) was added. To 
alter PBNC size, the diameter of the iron oxide nanoparticles was altered. Dextran-
coated iron oxide nanoparticles with a diameter of 10nm produced 200nm PBNCs.  Iron 
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oxide nanoparticles with a diameter of 2nm produced 20nm PBNCs. Transmission 
electron microscopy (TEM) (Hitachi HT7700 TEM, IEN/IMAT Materials Characterization 
Facility, Georgia Institute of Technology) was used to visualize particle size and shape 
(Figure 16).  PBNCs were sterilized under UV light for at least 12 hours prior to all 
experiments. 
For estimating iron content in 200 and 20nm PBNCs, particle counts were 
measured from transmission electron micrographs at a known optical density (as 
determined by UV-Vis spectrophotometry). Based on the initial iron content used to 
synthesize particles and assuming particle concentration increases with optical density, 
it was determined that 200nm PBNCs have 2.8 times the iron content of 20nmPBNCs at 
the same optical density.  
 
Figure 16. TEM Characterization of PBNCs. Representative transmission electron 
micrographs for (A) 20nm PBNCs and (B) 200nm PBNCs to determine approximate 
shape and size. 
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5.2.3 MSC Fluorescent and PBNC Labeling 
MSCs at 80-90% confluence were incubated with PBNCs in cell culture media at 
PBNC concentrations ranging from 0.25 to 10 optical density (OD) for 24 hours. Unless 
otherwise noted, 2 OD PBNC concentrations were used in experiments reported herein. 
Uptake of PBNCs by MSCs was visually detected within cells by light microscopy (EVOS 
XL, Thermo-Fisher). Prior to imaging, PBNC-labeled MSCs (hereinafter referred to as 
PBNC-MSCs) were fixed with 10% buffered formalin for 15 minutes followed by 
cytoplasmic staining with 1% eosin (w/v) for 5 minutes. Triplicate experiments were 
performed for each PBNC incubating concentration to confirm PBNC uptake, which we 
defined as PBNC colocalization with eosin-stained cytoplasm. Further characterization of 
PBNC-MSCs was performed by flow cytometry to assess changes in light scatter known 
to correlate with nanoparticle uptake (Zucker et al., 2010). Specifically, labeled MSCs 
were detached from culture dishes with 0.05% trypsin-EDTA (w/v) and side scatter 
(SSC) properties were analyzed using an Attune NxT (Thermo-Fisher) flow cytometer at 
200 µL/min flow rates.  
A Vevo 2100 imaging system, which incorporates ultrasound and photoacoustic 
(US/PA) imaging modalities (VisualSonics, Inc.), was used to verify that PBNC-MSCs 
could produce a photoacoustic signal.  PBNC-MSCs were imaged in a tissue-mimicking 
gelatin phantom (Cook et al., 2011).  The base of the phantom consisted of 8% (w/v) 
gelatin and 0.2% (w/v) silica (Sigma-Aldrich). Gelatin phantom inclusions were made by 
adding 16% (w/v) gelatin to an equal volume of PBNC-MSCs.  Each inclusion was 
imaged at 5nm wavelength increments from λ=680 nm to 970 nm with the US/PA 
transducer oriented perpendicular to the gelatin base. 
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For MSC injection experiments, MSCs were detached from culture flasks with 
0.05% trypsin-EDTA (w/v), centrifuged, and resuspended in 5uM carboxyfluorescein 
succinimidyl ester (CFSE, affymetrix eBioscience) in PBS after PBNC uptake (for PBNC-
MSC samples). After incubating for 15 minutes at 37oC, media was added to quench any 
unreacted CFSE before injection of MSCs into the eye.  
5.2.4 Organ Cultured Porcine Eyes 
Anterior segment organ culture is a well-established method to maintain 
trabecular meshwork function ex vivo for several weeks, and we adopted this approach 
for our work here (Bachmann et al., 2006; Bhattacharya et al., 2009; Erickson-Lamy et 
al., 1991; Johnson and Tschumper, 1987, 1989). Fresh porcine eyes from a 
slaughterhouse (Holifield Farms, Covington, GA) were dissected within 6-8 hours of 
enucleation. Eyes were dissected to isolate the outflow tissues and anterior 
corneoscleral shell, similar to previously reported methods (Bachmann et al., 2006; 
Bhattacharya et al., 2009). Briefly, orbital connective tissue was dissected away and 
eyes were soaked in Betadine (Purdue Pharma) solution for 5 minutes, after which eyes 
were transferred to a sterile laminar flow hood for the remainder of the process. Eyes 
were washed with sterile PBS, and hemisected with a razor blade to isolate the anterior 
half of the eye. The vitreous humor and lens were removed. Next, the iris was cut 
radially back to the iris root and pectinate ligaments until the TM was revealed. The 
ciliary processes were then carefully removed while preserving the TM. Any remaining 
vascularized or pigmented tissue was removed from scleral and cornea surfaces with 
sterile cotton swabs.  
Dissected anterior segments were placed in custom-built organ culture dishes 
and clamped in place (Figure 17). Organ culture dishes were placed in a sterile 37oC 
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humidified incubator and perfused at 2.5 µL/min with serum-free media containing 
penicillin, streptomycin, and amphotericin while pressure transducer (142pc01g, 
Honeywell) readings from the anterior segment were recorded every 60 seconds in 
LabView. Eyes were stabilized for at least 48 hours before conducting any experiments. 
Any eye which did not demonstrate a stable outflow facility (the ratio of perfusion flow 
rate over IOP) between 0.45 and 0.125 µL/min/mmHg (pressures of ~6mmHg to 
20mmHg IOP) were considered as outliers and not used for MSC delivery experiments 
(Figure 17).  
 
Figure 17. Anterior Segment Organ Culture Setup. (A) Diagram of porcine anterior 
segment clamped in organ culture dish. Red label indicates TM region. (B) Porcine 
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anterior segment in organ culture after 10 days of perfusion. (C) Representative outflow 
facility traces for three porcine eyes. Outflow facility stabilizes after 1-2 days, after which 
any eyes with outflow facilities outside of the acceptable range are not considered for 
injection experiments (such as Eye 3).  
5.2.5 PBNC-MSC magnetically steered delivery  
PBNC-MSCs were detached from culture flasks using 0.05% trypsin-EDTA (w/v) 
and counted to determine cell number (Attune NxT Flow Cytometer). After fluorescent 
staining with CFSE, cells were resuspended in serum-free organ culture media at 1 
million cells/mL. 250µL of cell suspension was injected with a 31-gauge needle through 
the cornea (5-10 second injection duration) while anterior segments were pressure 
clamped at 8 - 12 mmHg. Immediately after injection, anterior segments were again 
perfused at 2.5µL/min. For magnetic delivery experiments, cells were steered in one of 
two ways.  
1) For initial optimization experiments, neodymium rare earth bar magnets (0.75” 
length x 0.25” width x 0.25” height) were placed next to one quadrant of the anterior 
segments near the limbal (corneal-scleral border) region prior to MSC injection.  
2) For 360o delivery experiments, two different ring magnets were used (Figure 
20). First, a 3D-printed magnet holder containing 10 axially-polarized cylindrical magnets 
(3/16” diameter x 0.25” height) was created (referred to as Design I). Alternatively, a 
commercially available axially polarized ring magnet (1.5” outer diameter x 0.75” inner 
diameter x 0.25” height) was used (referred to as Design II). Ring magnets were placed 
around the limbus before MSC injections and removed at specified time points.  
Following MSC injection, anterior segments were perfused overnight, after which 
they were removed from organ culture and immersed in 10% buffered formalin overnight 





Figure 18. Schematics of Ring Magnets. Overview (A, B) and cross-sectional (C, D) 
views for two ring magnet designs used. (A, C) Design I: A 3D-printed ring magnet 
holder housing 10 cylindrical magnets. (B, D) Design II: An axially polarized ring magnet. 
Arrows denote overall magnetic field direction towards the north pole (N).  
5.2.6 Fluorescent microscopy and quantification 
After fixation, the TM region of anterior segments was fluorescently imaged en 
face. Anterior segments were placed in PBS on a 50mm glass bottom dish, after scleral 
surfaces posterior to the TM were removed so that the TM was in contact with the dish 
surface to improve imaging. Micrographs of the entire TM circumference were captured 
by confocal microscopy (LSM 700, Carl-Zeiss) to identify CFSE-tagged MSCs delivered 
to the TM region. Brightfield overlays were also captured to identify the corneal margin 
and hence the approximate location of the TM. Micrographs were captured at 50x 
magnification as z-stack tile scans to account for TM depth and height differences 
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around the circumference of the anterior segment. Maximum intensity projections were 
created for each en face image for use in further image quantification.  
To specify the TM region within which quantification was carried out, masks were 
created from brightfield images using the corneal margin as a landmark (Figure 19). A 
1mm ring from the edge of the cornea was defined, using ImageJ (Schindelin et al., 
2015; Schneider et al., 2012), to be the TM region within each image. Images were 
further processed in Matlab (MathWorks) to remove large fluorescent debris (size 
greater than 100 µm). To quantify fluorescent intensity around the TM circumference, a 
polar coordinate system was overlaid onto images and the total CFSE intensity was 
quantified within each one degree sector. Intensities were then summed over 30o 
sectors, resulting in 12 intensity values for each image. The process was then repeated, 
considering only the signal outside the masked region, to determine the cell signal not 
located in the TM. 
 
Figure 19. Example of Image Processing for en face Micrographs. (A) Raw 
fluorescent en face micrograph showing CFSE-labeled MSCs in green. (B) Brightfield en 
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face image used for determining the TM location. (C) A 1-mm wide ring around the 
cornea is used to identify CFSE-labeled MSC signal within (D) the TM tissue region. (E) 
Fluorescent debris larger than 100µm was excluded and (F) polar histograms were 
created, showing CFSE-labeled MSC signal (radial coordinate, arbitrary units) within the 
TM as a function of circumferential location. Scale bars denote 2mm.   
5.2.7 Histology  
Anterior quadrants of fixed porcine eyes were cut into 3 mm wide meridional 
wedges and trimmed to isolate the outflow region. The tissue was dehydrated through 
an ethanol series, infiltrated and embedded in Histocryl media (Electron Microscopy 
Sciences). Two micron thick sections were cut on a Leica UC7 ultramicrotome with a 
glass knife and examined with a Leica DM6 Epifluorescent microscope. Sections were 
examined to visualize stem cells labeled with PBNCs, using the green fluorescent 
protein filter cube. 
5.2.8 Live-Dead Assessment of Effects of PBNCs on MSCs in vitro  
To assess potential acute toxicity due to PBNCs, MSCs were incubated with 
PBNCs at various concentrations for 24 hours. Media was removed and propidium 
iodide was added to each sample for 5 minutes to stain dead, adherent cells. Propidium 
iodide staining solution was removed and 0.05% trypsin-EDTA (w/v) was added for 5 
minutes to detach cells. Media containing 20% FBS was added to neutralize trypsin 
activity and cells were collected in deep-well 96-well plates (Corning). Cell samples were 
processed by flow cytometry by collecting equal volumes from each sample (Attune 
NxT). PBNC-labeled living cell counts (propidium iodide negative), were compared to 
unlabeled, control living cell counts to determine PBNC toxicity 1 day after PBNC 
incubation. This approach bypassed the issue of tracking detached, dead cells in vitro 




To assess longer-term toxicity following PBNC incubation, DAPI-stained nuclei 
were counted from microscopic images 7 and 21 days after PBNC incubation at different 
PBNC concentrations. These cells were the same ones used in assessment of MSC 
multipotency (see section 5.2.8). Nuclei counts were compared to counts in cells that 
had not been exposed to PBNCs.  
Finally, we assessed whether magnetic fields might interact with PBNCs to lead 
to cell toxicity. MSCs in 48 well plates labelled with 200nm PBNCs at a concentration of 
2 OD were placed on neodymium rare earth magnets (0.5” length x 0.5” width x 0.25” 
height) for 15, 30, 60 minutes or overnight. Unlabeled MSCs were also exposed to the 
same magnetic field to determine the toxicity of the magnetic field alone. After magnet 
exposure, MSCs were stained with propidium iodide and detached for flow cytometric 
analysis as described above. PBNC-labeled and unlabeled MSC counts for each magnet 
duration were compared to counts of control cells that were not exposed to magnetic 
fields.  
5.2.9 Stem Cell Multipotency Assessment in vitro  
We also carried out studies to ensure that PBNC labelling did not negatively 
affect the multipotency of MSCs. After loading with PBNCs, cells were exposed to 
adipogenic differentiation or osteogenic differentiation media for 1 or 3 weeks 
respectively, feeding every three days (Gibco). At their respective time points, cells were 
fixed in 10% buffered-formalin for 15 minutes. Adipogenesis was quantitatively assessed 
by Nile Red staining (Thermo-Fisher) (Greenspan et al., 1985). Cells were incubated for 
5 minutes with 100 ng/mL Nile Red in PBS, washed, and probed with DAPI (Life 
Technologies). For each cell sample, 16 fluorescent micrographs were captured in a 4 x 
4 array across each sample using an imaging plate reader (10x objective, BioTek 
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Cytation 3).  Nile Red average fluorescent intensities were quantified for each image and 
normalized to DAPI cell counts. Further, adipogenesis was qualitatively assessed by Oil 
Red O (Sigma-Aldrich) staining and light microscopy (Snider et al., 2017, in preparation). 
To assay for osteogenesis, cells were stained with 2% (w/v) Alizarin Red for 2 
minutes followed by PBS rinses to remove excess dye. Experiments were qualitatively 
assessed by light microscopy, followed by counterstaining cell nuclei with DAPI, and 16 
fluorescent micrographs were captured in a 4 x 4 array for each sample using an 
imaging plate reader as described above.  
5.2.10 Statistics 
For in vitro experiments, triplicate technical replicates were run for each set of 
experimental conditions. Two MSC donor strains were used in assessment of viability 
and multipotency. Analysis of variance (ANOVA, with post hoc Tukey test) was used to 
determine if unlabeled, control groups were significantly different from PBNC-labeled 
groups. For cell delivery experiments, at least triplicate ocular injections were carried out 
for every experimental condition using a single MSC donor strain. Kuiper’s V test was 
performed to test for non-uniform circumferential cellular distributions in experiments in 
which cells were steered by a rectangular magnet (Berens, 2009; Kuiper, 1960). 
Average cell signal distribution results for each group were assessed, with p < 0.05 
indicating non-uniformity skewed toward the magnet location. For experiments in which 
cells were steered using a ring magnet, Rayleigh’s test for uniform circular distribution 
was used to test cell signal distributions, with p < 0.05 indicating non-uniform cellular 
distribution around the TM (Berens, 2009).   
The use of ANOVA requires three assumptions to be satisfied: the outcome of 
interest must be continuous and measurements must be independent; the residuals 
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must be normally distributed; and there must be homogenous variance between groups 
(“homoscedasticity”). For this study, all experimental variables were continuous. Uniform 
distribution and equal variances were routinely assessed as part of the ANOVA analysis 
(XLSTAT). Unfortunately, for situations in which there were small numbers of 
observations (n < 5), assessment of normality was unreliable. Further statistical analysis 
should be carried out to confirm the validity of these statistical tests.  
5.3 Results 
5.3.1 MSCs Uptake PBNCs  
MSCs were incubated with PBNCs overnight, after which cells were fixed and 
assessed for PBNC uptake by light microscopy. Prussian blue labelling was visible and 
colocalized with eosin-stained MSCs after incubation with 20nm or 200nm PBNCs 
(Figure 20 A-E). PBNCs are known photoacoustic absorbers (Cook, 2017), so PA 
imaging was performed on labeled MSCs by suspending cells in gelatin and imaging at 
690 or 755 nm wavelengths for 20nm or 200nm PBNCs, respectively. PA signal was 
detectable and increased with the optical density (OD) of the PBNC solution used during 
cell labelling, i.e. with increasing PBNC concentration (Figure 20 F-J). PBNC uptake was 
further confirmed by flow cytometry. Specifically, MSC side scatter, a measure of light 
scatter due to particles inside cells (i.e. nucleus, endosomes, PBNCs), increased 
following labeling with PBNCs when compared to unlabeled controls (Figure 20 K,L), 
with increases correlating with PBNC concentration. 200nm PBNCs resulted in larger 
scattering effects than 20nm PBNCs (Figure 20 M). Overall, we conclude that both 20nm 
and 200nm PBNCs are suitable for MSC labeling, but side scatter results suggest that 




Figure 20. MSCs Uptake PBNCs. (A-E) Representative micrographs of MSCs after 
incubation with different PBNC sizes and PBNC solution optical densities (OD). MSCs 
were eosin stained to visualize cytoplasm, while PBNCs appear blue. (F-J) 
Photoacoustic signal at 690nm (20nm PBNCs) or 755nm (200nm PBNCs) excitation 
wavelength for MSCs in gelatin phantoms (both 690nm and 755nm unlabeled MSC 
signals were minimal so only 690nm is shown). Uptake of PBNCs was further assessed 
by light side scatter (SSC). (K,L) Representative forward scatter (FSC) vs. SSC density 
maps collected by flow cytometry for (K) unlabeled MSCs or (L) MSCs incubated in a 
solution of 200nm PBNCs at a concentration of 2OD. (M) Normalized side scatter vs. 
optical density of incubating solution for 20nm and 200nm PBNC-MSCs (n=3 technical 
replicates for each). Error bars denote standard deviation. 
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5.3.2 PBNC-MSCs Can Be Steered by Magnetic Fields                                                                                                                                                                                                                                 
Either 20 or 200nm PBNCs were used to label MSCs, and 250,000 labelled cells 
were injected into perfused porcine anterior segments maintained in organ culture. To 
establish a baseline for comparison, unlabeled MSCs were injected without an external 
magnet, which resulted in very few cells in the TM region (Figure 21A). It was expected 
that cells would be attracted to a neodymium rectangular magnet placed near the limbus 
in one quadrant of the anterior segment. However, when MSCs were labeled with 20nm 
PBNCs at a concentration of 2 OD, few cells preferentially accumulated in this quadrant 
(Figure 21B) when compared to the distribution of unlabeled MSCs. On the other hand, 
when the PBNC concentration in the incubation solution was increased to 10 OD, more 
MSC accumulation was detected near the magnet (Figure 21C). Finally, if cells were 
incubated with 200nm PBNCs at a concentration of 2 OD, a much higher number of 
MSCs accumulated near the magnet (Figure 21D).  
The distribution of fluorescent signal from labelled MSCs around the entire TM 
circumference was quantified for at least 3 injection experiments for each condition and 
averaged, as shown in polar histograms (Figure 22).  Kuiper’s V tests for non-uniform 
cell distribution at the site of the magnet (0o) demonstrated that only 20nm PBNC-MSCs 
incubated at a PBNC concentration of 10 OD and 200nm PBNC-MSCs incubated at a 
PBNC concentration of 2 OD resulted in significant cell accumulation at the magnet. 
While 20nm PBNC-MSCs at a PBNC concentration of 10 OD were steered to the 
magnet location, total cell signal at the magnet site was similar to control eyes (Figure 
23). Only 200nm PBNC-MSCs at a concentration of 2 OD resulted in significantly higher 
fluorescent cell signal at the magnet site compared to the other experimental groups 
(Figure 23). Therefore, we conclude that 200nm PBNCs are optimal for improving cell 




Figure 21. Magnetic steering of MSCs labelled with either 20 or 200nm PBNCs.  
Representative en face micrographs of the TM region after MSC delivery. Bar magnets, 
diagramed in (B) (to scale), were secured overnight at 0o near the limbal region in 
PBNC-MSC injections. CFSE-tagged MSCs (Green) were injected (A) unlabeled, or 
after incubation with (B) 20nm PBNCs at 2 OD (C) 20nm PBNCs at 10 OD, (D) 200nm 




Figure 22. Quantification of Cell Delivery to the TM for MSCs Labelled with 20 and 
200nm PBNCs. Polar histograms illustrate fluorescence intensity (radial coordinate, 
arbitrary units) for each 30o region. Note that a bar magnet was placed adjacent to the 
limbus at 0o overnight (see Figure 21B). Average results for (A) no magnet, unlabeled 
MSCs (n=5 eyes), (B) 20nm, 2 OD PBNC-MSCs (n=3 eyes), (C) 20nm, 10 OD PBNC-
MSCs (n=3 eyes), (D) 200nm, 2 OD PBNC-MSCs (n=4 eyes) experiments are shown. p-
values were calculated using Kuiper’s V test to assess if distribution was non-uniformly 





Figure 23. MSCs incubated with 200 nm PBNCs in a solution with OD=2 are 
steered to the magnet. The plotted quantity is total fluorescent signal in the TM in the 
magnet region, defined as the wedge extending from 45o to -45o (see Figure 21B) 
relative to unlabeled MSCs (mean = 1) for MSCs labeled with 20nm PBNCs at 2 OD 
(mean = 2.2), MSCs labeled with 20nm PBNCs at 10 OD (mean = 1.8), and MSCs 
labeled with 200nm PBNCs at 2 OD (mean = 14). For box and whisker data, crosses 
correspond to mean values while the lower, center and upper limits of the box are the 
first, second and third quartile. The upper and lower whiskers denote the maximum and 
minimum values. (Outliers, defined as 1.5x below or above the first and third quartile, 
respectively, are shown as single data points beyond the upper and lower whiskers 
when applicable) Significance (p < 0.05) was determined by ANOVA, with post hoc 
Tukey.   
5.3.3 Optimizing Magnetic Field Exposure Time 
Next, the effect of magnet placement time was assessed using MSCs labelled 
with 200nm PBNCs at a concentration of 2 OD. Specifically, a bar magnet was placed 
adjacent to the limbus for either 15 minutes, 30 minutes, 60 minutes, or overnight 




similar for all durations, each resulting in significant PBNC-MSC accumulation adjacent 
to the magnet (Figure 25).   
To further quantify cell steering, total fluorescent signal in the TM within a 90o 
sector (45o on both sides of the magnet center at 0o) was quantified and compared to 
fluorescent signal in the entire TM (Figure 26A). We found that 50 to 75% of MSCs were 
steered to the magnet site and that no significant differences were observed between 
the durations tested. Similarly, to assess how many cells were delivered to non-target 
tissues in the magnet region, total fluorescent signal outside of the TM was quantified, 
and ratios of TM to non-TM fluorescence were calculated. Higher TM specificity was 
observed for longer durations, with overnight magnetic exposure having the highest TM 
to non-TM delivery ratio (Figure 26B). However, differences in specificity between 
different magnetic exposure durations were not found to be statistically significant. We 
conclude that cell steering occurs rapidly, i.e. a 15-minute magnet placement is sufficient 





Figure 24. Effect of Magnetic Field Exposure on Steering of 200nm PBNC-MSCs to 
the TM.  Representative en face micrographs of the TM region following MSC delivery 
with bar magnets placed at 0o near the limbal region for different durations (see Figure 
21B). All anterior segments were perfused overnight prior to imaging. CFSE-tagged 
MSCs (Green) were pre-labeled with 200nm PBNCs at a concentration of 2 OD and 
exposed to a magnetic field for (A) 15 minutes, (B) 30 minutes, (C) 60 minutes, or (D) 





Figure 25. Quantification of MSC Delivery After Exposure to Magnetic Fields for 
Different Durations. Polar histograms illustrate fluorescence intensity (radial 
coordinate, arbitrary units) for each 30o region, with a bar magnet placed at 0o (see 
Figure 21B). Average results for (A) 15-minutes (n=4 eyes), (B) 30-minutes (n=5 eyes), 
(C) 60-minutes (n=3 eyes), and (D) overnight (n=4 eyes) magnet exposures are shown. 
p-values were calculated using Kuiper’s V test to assess if distribution was non-uniformly 




Figure 26. Quantification of Fluorescence within the Quadrant Adjacent to the 
Magnet. (A) Percentage of cell signal in the TM within the region 45o to -45o compared 
to cell signal around the entire TM. (B) Fluorescent signal in the TM region relative to the 
fluorescent signal not in the TM region at the magnet site. Box plot interpretation is as 
described in Figure 23. Mean values for each experimental group are shown in each 
plot. 
5.3.4 Improving Delivery Efficiency to the Entire TM with PBNCs 
The above results show that PBNC-MSC delivery to a single quadrant of the eye 
can be improved by use of a magnet. We then considered whether delivery could be 
improved to the entire circumference of the eye. 250,000 MSCs were injected as before, 
and steered using one of two different ring magnet designs: Design I, a 3D printed 
magnet holder, and Design II, an axial polarized ring magnet (Figure 18). Design I was 
tested for a 30-minute magnet exposure, while Design II was assessed for 15- and 30-
minute exposures (representative micrographs shown in Figure 27). Each configuration 
resulted in increased cell signal around the TM circumference compared to control 
injections (Figure 28 A - D). However, only Design II with exposures of 15 and 30 
minutes resulted in a statistically uniform distribution, as determined by Rayleigh’s test 
for uniform circular distribution. The greatest cell delivery was observed for Design II, 15-
minute exposure, which resulted in as much as a 10x increase in cell delivery compared 
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to controls (Figure 29 A). Design II had lower ratios of cell signal inside the TM to signal 
outside the TM compared to Design I, indicating improved TM specificity. We conclude 
that PBNC-MSCs can be steered to the entire TM circumference in as little as 15 
minutes, and optimization of the magnetic field placement can result in increased 
delivery specificity to the TM.  
 
Figure 27.  360o Delivery of PBNC-MSCs Using Ring Magnets. 200nm labeled 
PBNC-MSCs were injected into eyes with several types of ring magnets placed around 
the circumference for different durations. Representative en face micrographs of the TM 
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region for (A) no magnet, (B) Design I for 30 minutes, (C) Design II for 15 minutes, and 
(D) Design II for 30 minutes. Scale bars denote 2mm. 
 
 
Figure 28. Quantification of MSC Delivery in Ring Magnet Experiments. Polar 
histograms illustrate MSC fluorescent intensity (radial coordinate, arbitrary units) for 
each 30o region. Average results for (A) control (n=5 eyes), (B) Magnet design I for 30 
minutes (n=3 eyes), (C) Magnet design II for 15 minutes (n=3 eyes), and (D) Magnet 
design II for 30 minutes (n=3 eyes) experiments are shown. p-values were calculated 
using Rayleigh’s test to assess uniform circumferential delivery (p < 0.05 denotes non-




Figure 29. Further Quantification of MSC Delivery in Ring Magnet Experiments. (A) 
Total fluorescence signal in the TM around the entire circumference of the eye. (B) 
Fluorescent signal in the TM region relative to the fluorescent signal not in the TM 
region. Box plot interpretation is as described in Figure 23. Mean values for each 
experimental group are shown in each plot. Statistical significance was determined by 
ANOVA, with post-hoc Tukey.  
5.3.5 Histological Assessment of the TM After PBNC-MSC Delivery 
En face micrographs lack the detail required to properly identify where cells are 
delivered within the TM. Thus, anterior segments were processed and resin-embedded, 
and 2 µm thick sagittal sections through the TM were cut. Representative images for 
overnight bar magnet and 15-minute Design II ring magnet exposures show 200nm 
PBNC-MSCs in the TM, as noted by the porous tissue structure and anatomical 
landmarks (Figure 30 A – D). Most of the cells remained on the inner TM structures as 
opposed to penetrating deeper into the tissue. We conclude that PBNC-MSCs are 
delivered to the TM.  
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Figure 30. Histological Assessment of PBNC-MSC Delivery to the TM.  
Representative sagittal sections of the TM region showing fluorescently labeled PBNC-
MSCs for (A,C) overnight bar magnet exposure and (B,D) Design II, 15 minute ring 
magnet experiments. (A,B) Lower magnification brightfield micrographs are labeled with 
relevant anatomical features for orientation (AAP = angular aqueous plexus, an 
analogue of Schlemm’s canal in porcine eyes).  Approximate zoomed regions are shown 
as blue and red boxes and magnified in panels (C,D).  
5.3.6 Toxicity of PBNCs on MSCs in vitro 
MSCs were incubated with different concentrations of 200nm PBNCs overnight. 
Cellular viability was then tested 1 day post-PBNC incubation to determine acute toxicity 
effects.  To assess viability, cells were stained with propidium iodide and analyzed by 
flow cytometry. Minimal PBNC toxicity was observed after 1 day for both MSC donor 
strains (Figure 31A). To then assess cytotoxicity over longer terms, MSC nuclei were 
counted from micrographs 7 and 21 days after PBNC labeling in experiments testing 
MSC multipotentency. Cell counts were unaffected by PBNC labeling, suggesting these 
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particles were not toxic to MSCs (Figure 31 B,C), at least out to 21 days after PBNC 
exposure.  
Finally, MSC viability after magnetic field exposure was assessed. Unlabeled and 
200nm PBNC-labeled MSCs were maintained in 48 well plates and exposed to 
cylindrical magnets under each well for 0, 15, 30, 60 minutes or overnight. Labeled 
MSCs had similar viability to unlabeled controls at each time point (Figure 32), indicating 
that PBNCs did not interact with the applied magnetic field to reduce cell viability. 
However, and surprisingly, exposure of MSCs to a magnetic field for any duration 
resulted in significantly (p < 0.05) reduced viability compared to controls without 
magnetic exposure (Figure 32). While unexpected, magnetic exposure has been 
reported to reduce cell viability in certain types of mammalian and bacterial cells (Cellini 
et al., 2008; El May et al., 2009; Raylman et al., 1996; Strašák et al., 2005). Less toxicity 
was found with 15-minute magnetic exposure, further motivating the use of shorter 




Figure 31. Cell Viability Results for MSCs labelled with 200nm PBNCs. Relative 
viability (A) 1 day after 200nm PBNC labeling for 2 MSC donor strains as determined by 
flow cytometry (n=3 technical replicates for each OD). (B,C) Cell counts relative to 
unlabeled controls for 2 MSC donor strains as determined by quantification of labelled 
nuclei using fluorescent microscopy following (B) 7 days adipogenic differentiation and 
(C) 21 days osteogenic differentiation (n=3 technical replicates for each OD).  Error bars 
denote standard deviation. Asterisks denote significant difference (p<0.05) compared to 




Figure 32. Effect of Magnetic Field Exposure on MSC Viability. Unlabeled and 
200nm PBNC-labeled MSCs were incubated on top of cylindrical magnets for 0, 15, 30, 
60 minutes or overnight. Magnetic field exposure reduced viability in an exposure-
dependent manner. Individual data points for each group are shown with horizontal lines 
indicating means (n = 3 or 4 technical replicates for each condition). Cell viability within 
each group (unlabeled or labelled with PBNCs) was statistically different (p < 0.05) 
compared to their respective controls (no magnetic field exposure), as determined by 
ANOVA post-hoc Tukey. Mean values for each experimental group are shown in plot.  
5.3.7 Effect of PBNCs on MSC Multipotency 
MSCs were treated with adipogenic medium for 7 days after PBNC labeling and 
qualitatively assessed for differentiation to adipocytes by Oil Red O staining (Figure 33 
A-C). Positive lipid staining was found for all PBNC concentrations for 2 MSC donor cell 
lines. Further, cells were stained with Nile Red fluorescent stain and DAPI nuclei stain. 
Nile Red signal normalized to DAPI intensity resulted in similar ratios for each donor 
strain and PBNC concentration, indicating minimal effect of PBNCs on adipogenesis 
(Figure 33D).  
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Figure 33. Effect of 200nm PBNCs on MSC Adipogenesis. (A-C) Oil Red O staining 
for lipids 7 days after adipogenesis treatment in (A) 4OD 200nm PBNC-MSCs, (B) 1 OD 
200nm PBNC-MSCs, and (C) unlabeled MSCs. (D) Quantification of ratio of fluorescent 
Nile Red (lipids) to DAPI (nuclei) signal relative to untreated controls for 2 stem cell lines 
(n=3 technical replicates for each concentration). Error bars denote standard deviation. 
Asterisks denote significant difference (p < 0.05) compared to unlabeled controls as 
determined by ANOVA, with post hoc Tukey. 
MSCs were also differentiated towards an osteogenic phenotype for 21 days, 
followed by staining with Alizarin Red to detect free calcium (Figure 34 A-C). Alizarin 
Red staining was detected consistently in all experimental conditions. Alizarin Red 
fluorescent intensity normalized to DAPI fluorescent intensity was similar for all PBNC 
concentrations and for both MSC donor strains, indicating minimal effect of PBNCs on 




Figure 34. Effect of 200nm PBNCs on MSC Osteogenic Potential. (A-C) Alizarin Red 
O staining for free calcium after 21 day osteogenesis treatment in (A) 4OD 200nm 
PBNC-MSCs, (B) 1 OD 200nm PBNC-MSCs, and (C) unlabeled MSCs. (D) Ratios of 
fluorescent Alizarin Red (free calcium) to DAPI (nuclei) signal relative to untreated 
controls for 2 stem cells (n=3 technical replicates for each concentration). Error bars 
denote standard deviation. 
5.4 Discussion  
Stem cells have the potential to repair the damaged TM in glaucoma and thus 
restore IOP homeostasis. To achieve this goal, it is highly desirable to optimize cell 
delivery to the TM. Previous studies in which cells were injected into the anterior 
chamber and then passively carried to the TM by aqueous humor flow showed that stem 
cells were undetectable in the TM after only 4 days, or showed significant stem cell 
delivery to unwanted sites, such as the cornea and iris (Manuguerra-Gagne et al., 2013; 
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Roubeix et al., 2015). In addition, segmental flow to the TM makes delivery to the entire 
TM circumference impossible if cells are driven by passive aqueous humor outflow, a 
problem that is exacerbated in glaucoma patients. We thus investigated active stem cell 
delivery to the TM. Specifically, we assessed whether magnetic nanoparticles could be 
utilized to steer MSCs to the TM in the presence of a magnetic field.  
We tested two PBNC sizes for cell steering, since particle size was hypothesized 
to impact cell steering. We observed that both PBNC sizes were capable of labeling 
MSCs, but that 200nm PBNCs were more effective at steering MSCs to the TM than 
20nm PBNCs. This is consistent with the fact that 200nm PBNCs have a larger SPION 
core than 20nm PBNCs and should thus be more responsive to a magnetic field. 
We wondered whether the increased steering effectiveness of 200 nm PBNCs 
was simply a matter of the total amount of iron loaded into the cell. We tested this by 
comparing MSC steering in cells incubated with very high concentrations of 20 nm 
PBNCs vs. cells incubated with a lower concentration of 200 nm PBNCs.  Our data show 
that 20nm PBNCs at 10 OD concentration had only a modest benefit on cell delivery, 
while 200nm PBNCs at 2OD concentration markedly improved cell steering efficiency, 
even though there was more iron present per cell volume in the former case than in the 
latter.  We conclude that iron content per cell was not the sole factor influencing MSC 
steering efficiency, and that the larger iron oxide core in 200nm PBNCs must play a role 
beyond just iron content.  
Regenerative medicine therapies rely on MSCs to restore tissue function through 
paracrine signaling or cellular differentiation, so it is important that PBNCs not adversely 
affect MSC function if they are to be used in practice. Fortunately, 200nm PBNCs did not 
reduce MSC viability out to 21 days, nor did they adversely affect multipotency. One goal 
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of MSC therapies for the TM is for MSCs to differentiate into TM cells after delivery. 
While differentiation of labelled MSCs to a TM-like phenotype has not been established, 
evidence that PBNCs do not alter traditional differentiation pathways suggests that MSC 
to TM cell differentiation will also not be affected.  
Although PBNCs were not toxic to MSCs, we were surprised to find that 
exposure to a magnetic field did alter MSC viability, with or without PBNC labeling. The 
time-dependence of this effect suggests that short magnetic exposure times will be 
necessary for future translational developments. It is possible that the magnets used in 
this study were too strong for translational use, and weaker magnet strengths or even 
shorter durations may be needed as this labeling technology is further developed. 
For in vivo usage and eventual clinical translation, it is advantageous to have a 
magnet exposure time that is as short as possible.  We observed that 200nm PBNC-
MSCs could be steered to the TM in as little as 15 minutes, with additional exposure 
time resulting in little net benefit. Further, since the shortest exposure tested was still 
effective, it is possible that even shorter durations may be effective. This point is 
particularly important in view of the observation that exposure of MSCs to a magnetic 
field results in a time-dependent loss of viability, implying that the shortest possible 
magnetic exposure is preferred.  
Another aspect to consider when optimizing magnet exposure time was non-
specific delivery to other anterior segment surfaces. Interestingly, overnight magnet 
exposure resulted in approximately 25% less non-specific delivery, compared to 15-, 30- 
and 60-minutes exposure times, indicating better TM-targeted delivery with long duration 
exposures. It is unclear why overnight exposure times would reduce non-specific 
delivery. One possibility is increased MSC death due to prolonged magnet exposure 
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which could reduce signal in the TM and non-specific anterior tissues. Further, MSCs 
could have been pulled “deeper” in the tissue so that they were not visible by fluorescent 
confocal microscopy due to light penetration limitations into tissue. Overall, however, 
differences in non-specific delivery were not significant between any magnet exposure 
time, suggesting shortest possible magnetic exposure is still preferred.  
Excitingly, MSCs labelled with 200nm PBNCs could be magnetically steered to 
the entire TM circumference. We observed some degree of uniform cell delivery for both 
ring magnet configurations tested, with Design II at 15 and 30 minute exposures 
resulting in more cell signal in the TM compared to Design I at 30 minutes. However, 
Design I had higher specificity for the TM region compared to Design II. The differences 
between these two ring-magnet designs can help inform magnetic field design for future 
work. Design II was a commercially-available, axially-polarized ring magnet, meaning 
most of the pulling force was in the axial direction, which would not be effective at 
steering MSCs to the TM, which primarily required forces on injected cells in the radial 
direction. Indeed, a radially-directed magnetic force was present only near the top and 
bottom faces of the magnet, and, while one of the faces was near the limbus, the other 
was not since the magnet height was much greater than the TM height. As a result, this 
likely led to undesired cell delivery near the second magnet face.  
However, one advantage of the Design II ring magnet was that the magnet was 
in direct contact with the limbus, presumably creating high field strengths near the TM. 
This was unlike Design I, in which 10 smaller magnets were positioned in a 3D-printed 
holder. Although the overall magnetic pulling force was directed towards the TM, the 
plastic holder resulted in a gap between the magnet and eye surface, reducing the 
magnetic field strength at the TM and, presumably, reducing cell delivery efficiency. 
Conversely, with the overall magnetic pull force focused at the TM region, higher 
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delivery specificity was obtained. This discussion highlights the benefits of optimizing the 
magnetic field, which presumably will be useful in delivering labelled cells efficiently to 
the entire TM with minimal delivery to unwanted tissue targets. 
5.5 Conclusions 
This study demonstrates the potential for steering MSCs magnetically to the TM. 
PBNCs were found to be suitable for MSC labeling, resulting in minimal toxicity effects in 
MSCs and no detectable impact on their ability to differentiate toward adipogenic or 
osteogenic lineages. To magnetically steer labelled MSCs to the TM, 200nm PBNCs 
were found to be more effective than 20 nm PBNCs. Further, magnetic steering was 
rapid, with magnetic exposure times of as little as 15 minutes showing large effects on 
MSC delivery. One key issue in passive, conventional MSC delivery to the TM is 
segmental delivery to active flow regions of the TM. Magnetic steering of MSCs using a 
ring magnet resulted in relatively uniform delivery around the entire TM circumference. 
This labeling technology for delivering cells to the entire TM at higher efficiencies 
compared to passive delivery has the potential to improve MSC therapies for the TM as 
regenerative medicine therapies for glaucoma are developed.  
For small animal models and eventual clinical translation, the magnetic field 
placement and PBNC labelling should be further optimized. Specifically, by adjusting the 
magnetic field and, potentially, altering the PBNC concentration for MSC labeling, more 
precise delivery of MSCs to the TM region with minimal unwanted delivery to other 
ocular tissues should be possible. It will be important to minimize the magnetic field-
associated toxicity that we observed, which implies a need for using shorter magnet field 
exposures. Next steps will use ultrasound-photoacoustic imaging of the PBNC-labeled 
MSCs to track delivery and engraftment of MSCs into the TM region, simplifying 
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optimization of this technology in animal models of glaucoma for eventual therapeutic 
experiments. 
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Glaucoma, the second leading causes of blindness, impacts over 70 million 
people worldwide. A well-established risk factor is elevated intraocular pressure (IOP); 
IOP is primarily determined by the inner wall of Schlemm’s canal and the trabecular 
meshwork (TM), a tissue located in the anterior segment which drains aqueous humor 
from the eye. In glaucoma, TM cellularity is reduced. This loss of cellularity presumably 
leads to loss of TM function and hence elevated IOP. Stem cells, if suitably 
differentiated, could offer a potential therapy for glaucoma. To test such regenerative 
medicine therapies, glaucomatous damage in the TM needs to be modeled properly in 
vivo or ex vivo. Using a porcine anterior segment organ culture preparation, we here 
show that oxidative stress, induced by hydrogen peroxide, can reduce TM cellularity to 
glaucomatous levels, which in turn resulted in loss of IOP homeostasis. Damage from 
hydrogen peroxide was not destructive to the TM, an essential characteristic of a 
glaucoma model for use in TM regenerative medicine testing. Stem cell delivery to the 
TM in this model resulted in proper cell engraftment which was not consistently observed 
in untreated controls. In conclusion, this porcine organ culture model offers an improved 
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platform for assessing regenerative medicine therapies for the trabecular meshwork in 
glaucoma.  
6.2 Introduction 
Primary open angle glaucoma (POAG), responsible for an estimated 74% of 
glaucoma cases worldwide, is a leading cause of irreversible blindness (Quigley and 
Broman, 2006). The best-established risk factor for POAG is elevated intraocular 
pressure (IOP), which is determined by the aqueous humor production rate and the 
outflow of aqueous humor (Weinreb and Khaw, 2004). The primary aqueous humor 
drainage route, known as the conventional pathway, consists of the trabecular 
meshwork (TM), Schlemm’s canal, and the distal vessels (Fautsch and Johnson, 2006; 
Goel et al., 2010).  
The cellularity of the TM is reduced in POAG patients (Alvarado et al., 1984; 
Baleriola et al., 2008; Gonzalez et al., 2006; Liton et al., 2005). The TM, along with the 
inner wall of Schlemm’s canal, is the major site of aqueous outflow resistance. TM cells 
phagocytose debris from aqueous humor to prevent outflow blockage, are contractile to 
alter outflow resistance, and are active remodelers of their extracellular matrix to alter 
TM extracellular matrix characteristics (Bradley et al., 2003; Buller et al., 1990; De Groef 
et al., 2013; Llobet et al., 2003; Sherwood and Richardson, 1988). Thus, reduced TM 
cellularity presumably leads to tissue dysfunction and subsequent increased outflow 
resistance and elevated IOP. Therapies that focus on restoring TM cellularity and 
function using stem cells could offer therapeutic benefit to POAG patients.  
To test such therapies, a model that mimics TM dysfunction, including ocular 
hypertension (OHT) and reduced cellularity, is needed. However, most current glaucoma 
models are focused on studying optic neuropathy secondary to OHT, and thus alter the 
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outflow pathway in ways that do not replicate the situation in human glaucoma 
(Gaasterland and Kupfer, 1974; Ishikawa et al., 2015; Morrison et al., 1997; Shareef et 
al., 1995; Weber and Zelenak, 2001). There are several exceptions, in which reduced 
TM cellularity has been achieved without severe TM damage. In one study, Zhang et al. 
ablated TM cells in rat eyes using a cytotoxic vector (Zhang et al., 2014); interestingly, 
they observed a reduced IOP after this procedure. Senatorov et al. expressed mutant 
myocilin in mice, which led to reduced TM cellularity and elevated IOP (Senatorov et al., 
2006; Zode et al., 2011). Unfortunately, mutations in myocilin are only associated with 3 
to 4% of POAG cases, and may not translate to other POAG varieties (Tamm, 2002). 
Abu-Hassan et al. used saponin, a plant-derived detergent, to reduce TM cellularity in 
organ-cultured human and porcine anterior segments (Abu-Hassan et al., 2014b). They 
reported that IOP homeostasis was altered in human anterior segments after saponin 
treatment. Unfortunately, the saponin model does not appear to work in porcine eyes, 
either in our hands or in the lab of the original publication (M. Kelley, personal 
communication).  
Anterior segment organ culture is a well-established method for studying TM 
function, in which TM cell viability and function can be maintained for several weeks. 
Ideally, all organ culture experiments would use human tissue. However, poor availability 
and high cost makes this option infeasible for many labs. Thus, anterior segment organ 
culture experiments have used monkey, porcine, bovine, or human eyes (Bachmann et 
al., 2006; Bhattacharya et al., 2009; Erickson-Lamy et al., 1991; Johnson and 
Tschumper, 1987, 1989; Mao et al., 2011). 
Our goal was to create a model of graduated TM cell loss and dysfunction using 
readily available porcine anterior segments in organ culture. For this purpose, we chose 
to utilize oxidative stress-induced damage to the TM. Here, we show that hydrogen 
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peroxide (H2O2) can be used to reduce TM cellularity, leading to tissue dysfunction in the 
form of reduced IOP homeostasis. This organ-culture TM dysfunction model offers an 
attractive platform for assessing stem cell therapies and their potential for 
refunctionalizing the TM.  
6.3 Methods and Materials 
To determine the effects of H2O2 exposure on cell viability, we first used isolated, 
cultured porcine TM (pTM) cells. Cells were treated with different H2O2 concentrations 
and viability was assessed until cellularity was reduced by ~50%. pTM cells were further 
assessed for phenotypic function after H2O2 treatment. We next implemented H2O2 
treatment in porcine anterior segments maintained in organ culture. Finally, functional, 
viability and histological assessments were used to determine the effect of H2O2 
treatment on the TM.  
6.3.1 Cell Sourcing 
6.3.1.1 Porcine TM Cell Isolation and Characterization 
Porcine TM cells were isolated from fresh porcine eyes obtained from a 
slaughterhouse (Holifield Farms, Covington, GA) within 6-8 hours of enucleation. Eyes 
were dissected to isolate the anterior chamber similar to previously reported methods 
(Bachmann et al., 2006; Bhattacharya et al., 2009). Briefly, orbital connective tissue was 
dissected away and eyes were soaked in Betadine solution (Purdue Pharma) for 5 
minutes. Following Betadine immersion, eyes were washed 3 times with sterile PBS 
containing 5x penicillin, 5x streptomycin, and 1x amphotericin and transferred to a sterile 
laminar flow hood for the remainder of the process. Eyes were hemisected with a razor 
blade to isolate the front half of the eye. The vitreous humor and lens were removed, the 
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iris was cut radially back to the iris root and pectinate ligaments until the TM was 
revealed, and the ciliary processes were carefully removed with Vannas microscissors 
(World Precision Instruments) while preserving the TM. Any remaining vascularized or 
pigmented tissue was removed.  
Next, the TM was removed from the corneoscleral shell with curved, fine forceps 
(Fine Science Tools) and placed in 10 mg/mL Collagenase IV digestion solution for 30 
minutes at 37oC as previously described (Stamer et al., 1995). Collagenase IV was 
neutralized by addition of 10% FBS media and the tissue digest was centrifuged at 1000 
rpm for 10 minutes. The pellet was resuspended in 3 mL 10% FBS-containing 
Dulbecco’s modified Eagle’s media (DMEM) supplemented with penicillin, streptomycin, 
and 2mM L-glutamine (TM Cell media) and placed on a 0.1% (w/v) gelatin-coated 6 well 
plate for 48 hours to allow cells to attach. At ~90% confluency, pTM cells were detached 
with 0.05% trypsin-EDTA (w/v) and plated in new culture flasks at 5,000 cell/cm2 (~3:1 
split ratio). Cells were expanded and used between passage 4 and 6 for all experiments.  
To confirm cells had TM-like properties, cells were plated at 10,000 cells/cm2 in 6 
well plates and were assessed for myocilin expression following dexamethasone (DEX) 
treatment. 100nM DEX was added in TM cell media for 7 days to cultured cells, 
replacing the media every 3 days. After 1 week of treatment, RNA was isolated from 
cells using TRIzol reagent (Life Technologies) and further purified using Aurum Total 
RNA Mini Kit per the manufacturer’s protocol (Bio-Rad). RNA concentration and purity 
were determined using a Nanodrop 2000C spectrophotometer (Thermo-Scientific). 
Reverse transcription to clonal DNA (cDNA) was performed on 1μg RNA samples 
following the manufacturer’s protocol (Bio-Rad). cDNA samples were analyzed for 
porcine myocilin and reference genes (Table 3). SYBR green reagent (Quantabio) was 
used to quantify DNA amplification in real time throughout the PCR cycle (StepOnePlus 
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Real Time PCR System, Applied Biosystems). The resulting cyclic threshold (CT) values 
were normalized to the geometric mean of three housekeeping messengers (GUSB, 
TATA Binding Protein, GAPDH) and further normalized against untreated pTM samples 
using the 2-CT methodology (Livak and Schmittgen, 2001). We observed significant 
increases in myocilin message levels after DEX treatment in all pTM cell lines tested, 
confirming the TM phenotype (Figure 35).  
Table 3.  Primer Sequences Used in RT-qPCR Experiments. Primers were selected 
using Primer-Blast (NCBI) software following established protocols (Ye et al., 2012). 
Porcine Primer Name Primer Sequence (5’ to 3’) 
Myocilin (MYOC)  Forward CAGGCTCACAGCATGTCTCA 
Reverse CCACATCCACTGCCTCCTTC 
Glyceraldehyde-3-Phosphate 
Dehydrogenase (GADPH)  
Forward ACCAGGTTGTGTCCTGTGAC 
Reverse AGCTTGACGAAGTGGTCGTT 
TATA Binding Protein (BP)  Forward AATCCCAAGCGATTTGCTGC 
Reverse CGTGCACACCATTTTCCCAG 




Figure 35. pTM Cell Characterization. pTM cells were treated with 200nM DEX for 7 
days, and MYOC mRNA levels were assessed by RT-qPCR. MYOC expression is 
shown relative to untreated controls for each pTM cell isolation. Note that vertical axis is 
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logarithmic. Error bars denote standard deviation (n = 4 technical replicates). Each bar 
represents one porcine TM cell line. Significant differences (p<0.05) between DEX-
treated and control samples was found for all samples as determined by ANOVA, with 
post-hoc Tukey. 
6.3.1.2 Mesenchymal Stem Cell Sourcing and Characterization 
Human adipose-derived mesenchymal stem cells (MSCs, Lonza) were grown in 
α-minimum essential medium supplemented with 20% FBS, penicillin, streptomycin, and 
L-glutamine (MSC Media). At 80-90% confluency, MSCs were detached using 0.05% 
Trypsin-EDTA (w/v, Cellgro, Corning) and seeded in fresh cell-culture T75 flasks at a 
density of 5,000 cells/cm2.  In all experiments, MSCs were used at passage numbers 
five or six. Each MSC donor strain was validated by Lonza for expression of MSC 
surface markers (CD13, CD29, CD44, CD73, CD90, CD105, and CD166) and minimal 
expression of negative MSC markers (CD14, CD 131, CD45). We also previously 
characterized each MSC donor strain for adipogenic, chondrogenic, and osteogenic 
differentiation and CD90 expression following expansion (Snider et al., 2017). 
6.3.2 Exposure of Cells to Hydrogen Peroxide in vitro 
Porcine TM cells were plated at 10,000 cells/cm2 in TM cell media and allowed to 
deposit extracellular matrix and proliferate for at least 48 hours. For viability assessment 
(see section 6.3.3.1), pTM cells were plated in 24 well plates while 6 well plates were 
used for functional experiments (see sections 6.3.3.2 – 6.3.3.4). Cell media was 
aspirated, and cells were washed once with phosphate-buffered saline (PBS). 
Commercially-available hydrogen peroxide obtained fresh from a local pharmacy (H2O2, 
3% w/v) was 0.22µm sterile filtered and prepared at specified concentrations in serum-
free DMEM supplemented with 2mM L-glutamine and 1x penicillin, streptomycin, and 
amphotericin (Organ culture media). After H2O2 addition, cells were incubated at 37oC for 
 111 
 
1 hour. H2O2-containing media was then removed, and cells were washed once with 
PBS. pTM cells were assessed immediately when indicated, or organ culture media was 
added for further cell culture.  
6.3.3 pTM Cell Characterization After H2O2Treatment 
6.3.3.1 Cellular Viability Assessment in vitro 
To determine cell viability in vitro, media was replaced with propidium iodide in 
PBS, followed by incubation at 37oC for 5 minutes to stain dead, adherent cells. 
Propidium Iodide was removed and 0.05% Trypsin-EDTA (w/v) was added for 5 minutes 
to detach cells. TM cell media was then added to neutralize trypsin activity, and cell 
suspensions were collected in deep-well 96-well plates (Corning). Cell samples were 
processed by flow cytometry (Attune NxT). Living cell counts were compared to control, 
untreated cell counts to determine viability after H2O2 treatment. Viability was assessed 
immediately, 24 hours, and 48 hours following H2O2 treatment as indicated.  
6.3.3.2 Metabolic Activity Assessment 
To determine the effect of H2O2 on metabolic activity, pTM cells were seeded 24 
hours after H2O2 treatment at 10,000 cells/cm2 in 96 well plates in Hanks’ balanced salt 
solution (HBSS) supplemented with 5% FBS and 2mM L-glutamine. The following day, 
Alamar blue (resazurin) in fresh media 10% (v/v) was added to each cell sample 
(O'Brien et al., 2000). The increase in Alamar blue fluorescence was detected by using a 
plate reader (Cytation 3, Bio-Tek) incubated at 37oC in a 5% CO2 atmosphere, with 
readings (Excitation 545nm, Emission 590nm wavelengths) taken every 10 minutes for 
at least 2 hours. Fluorescence was plotted vs. time for each cell sample and the slope of 
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the linear region was found. Slopes were compared between treated and untreated cell 
samples to determine the effects of H2O2 on metabolic activity.   
6.3.3.3 Phagocytic Activity Assessment 
TM cells have been shown to be actively phagocytic in vivo, removing 
particulate/cellular debris from the aqueous humor to avoid clogging the meshwork 
(Buller et al., 1990; Sherwood and Richardson, 1988). To quantify phagocytosis, pHrodo 
e.coli BioParticles (Life Technologies) were used following previously developed 
methods (Gagen et al., 2013; Snider et al., 2017). 24 hours after H2O2 treatment, cells 
were seeded at 50,000 cells/cm2 onto 96 well plates in Hanks’ balanced salt solution 
(HBSS) supplemented with 5% FBS and 2mM L-glutamine. Cells were allowed to attach 
overnight before assessing phagocytosis. pHrodo particles (2 million cells/vial) were 
reconstituted in HBSS media, sonicated for 5 minutes, and added to experimental 
samples. Control samples remained in HBSS media.  
After a 4-hour incubation at 37oC, HBSS media was removed and cells were 
detached with 0.05% Trypsin-EDTA. Detached cells were transferred to 96 well plates 
and data was collected with a flow cytometer (Attune NxT, Thermo-Fisher Scientific) at 
100µL/min. Unstained median fluorescent intensity (MFI) values were subtracted from 
MFI values measured in phagocytically-challenged samples. Ratios of MFI values in 
H2O2 treated cells to MFI values in control, untreated cells were calculated to determine 
H2O2 effect on phagocytic activity.   
6.3.3.4 Gel Contractility Assessment 
Cell contractility was determined using a collagen gel contraction assay, since 
trabecular meshwork cells are contractile (Dismuke et al., 2014b). 24 hours after H2O2 
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treatment, cells were resuspended in serum-free DMEM at 9 x 105 cells/mL. Collagen 
type I (3mg/mL, 1% [v/v] acetic acid, calf skin, MP Biomedical) was added to cells at a 
1:2 volume ratio (collagen:cells) followed immediately by a pretitrated volume of 0.1M 
sodium hydroxide to neutralize the acidity. Collagen gels (1mg/ml, 6x105 cells/mL) were 
then cast in 48 well plates at 240μL gel solution per well. After 20 minutes to allow 
gelation, an equal 240µL volume of serum-free media was added to provide nutrients 
needed for cell attachment while minimizing proliferation. After 24 hours, gels were 
released from the walls of the 48-well plate using a pipette tip. Gels were incubated for a 
further 24 hours to allow time for gel size to reach steady state. Images of each gel were 
taken immediately following release from the walls and at 24 hours (ChemiDoc MP, Bio-
Rad). Using ImageJ, gel area was quantified for each image to determine the magnitude 
of gel contraction by comparing initial gel size to steady-state size. Percent gel 
contraction was compared between H2O2-treated and control (untreated) cell samples to 
determine H2O2 effects on gel contractility.   
6.3.4 Porcine Anterior Segment Organ Culture 
Dissected anterior segment, prepared as described earlier, were placed in 
custom-built organ culture dishes and clamped in place (Figure 36). Organ culture 
dishes were placed in a sterile 37oC humidified incubator and perfused at 2.5 µL/min 
with organ culture media, while pressure was measured every 60 seconds (142pc01g, 
Honeywell) and recorded in LabView. Eyes were stabilized for at least 48 hours before 
adding H2O2 or other agents. Any eyes which did not demonstrate a stable outflow 
facility (a ratio between perfusion flow rate and IOP) between 0.125 and 0.45 
µL/min/mmHg (pressures of ~6mmHg to 20mmHg IOP) were considered as outliers and 
discarded (Figure 36).  
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6.3.5 Hydrogen Peroxide Treatment in Organ Culture 
After IOP stabilization, 4.5mM H2O2 in organ culture media was perfused into 
eyes for 1 hour. To rapidly expose the anterior segments to H2O2, the perfusion flow rate 
was increased to 2.5mL/min until approximately 7-10mL of 4.5 mM H2O2 had been 
infused. During this exchange period, anterior segments were open to hydrostatic 
reservoirs to maintain constant pressure (6-12 mmHg) and for media outflow while the 
perfusion flow rate was increased. After the exchange had been completed, anterior 
segments were returned to the normal perfusion flow rates of 2.5 µL/min for 1 hour and 
the valve connecting the culture dish to the hydrostatic reservoirs was closed, during 
which time the perfusate consisted of media with added 4.5mM H2O2 . At the conclusion 
of this one hour period, anterior segments were again exchanged with an additional 7-
10mL of organ culture media at 2.5mL/min to flush H2O2–containing media from the 
anterior segment. Finally, anterior segments were perfused for an additional 24 hours at 
2.5µL/min to allow IOP stabilization following treatment with H2O2. For control anterior 
segments, the same protocol was followed except that no H2O2 was added to the organ 







Figure 36. Porcine Anterior Chamber Organ Culture Setup. (A) Schematic diagram 
of porcine anterior segment clamped in organ culture dish. Red region indicates TM. (B) 
Porcine tissue in organ culture dish after 10 days of media perfusion. (C) Representative 
outflow facility for three porcine eyes. Pressures typically stabilize after 1-2 days, at 
which point any eyes outside of the healthy outflow facility range (0.125 to 0.45 
µL/min/mmHg) were discarded. 
6.3.6 Organ Culture Characterization  
6.3.6.1 IOP Homeostasis Challenge 
After a 24 hour IOP stabilization period following H2O2 treatment, the organ-
culture perfusion flow rate was increased to 5µL/min for 72 hours to create a “2x flow 
challenge”. A similar 2x pressure challenge has been shown to result in higher facilities 
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in normal human anterior segments, presumably due to the TM adapting so as to restore 
a homeostatic pressure level. This adaptive response was absent or blunted in 
glaucomatous anterior segments (Abu-Hassan et al., 2015), and thus the flow challenge 
response has been interpreted as a measure of TM function. Our 2x flow challenge 
follows a similar approach and is easier to implement in a pump-based system, such as 
used in this work. When organ-cultured anterior segments are challenged in this way, we 
expect that pressure will spike and eventually reduce to baseline values in control 
anterior segments with functional TMs. On the other hand, we expect that H2O2-treated 
anterior segments will not adapt, so that IOP will remain elevated (diagrammed in Figure 
37).  
6.3.6.2 Live Dead Assessment in Organ Culture 
After a 24 hour IOP stabilization period following H2O2 treatment, anterior 
segments were live-dead stained to determine cellular viability. Anterior segments were 
removed from organ culture and washed once with PBS and incubated with 2 µM 
calcein-AM and 4 µM ethidium homodimer-1 for 30 minutes. Live-dead stained tissue 
was imaged en face by confocal microscopy (LSM 700, Carl-Zeiss). Micrographs were 
captured as tile scans of z-stacks (to account for TM depth and height differences in the 
tissue) at 50x magnification. Maximum intensity projections (MIPs) were created from z-
stacks for subsequent image quantification.  
Brightfield overlays were also captured to identify the corneal margin, from which 
we determined the approximate location of the TM. Specifically, a 1 mm wide band 
around the corneal margin was taken as the TM region. Average fluorescent intensities 
for calcein-AM (live) and ethidium homodimer (dead) within the TM were determined 
from MIPs using ImageJ and compared to control, untreated eyes to determine the 
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impact of H2O2 on TM viability. Eyes were then fixed overnight using 10% buffered-
formalin at 4oC.   
 
Figure 37. Schematic of 2x Flow Challenge Paradigm. After IOP stabilizes following 
H2O2 or media treatment for treated and control eyes, respectively (“Baseline IOP”), inlet 
flow rate is doubled (“2X Flow Challenge”). In control eyes, we expect the TM to adapt, 
so that IOP recovers to baseline IOP levels. In treated eyes, TM function is impaired and 
IOP does not return to baseline values. 
6.3.6.3 Histological Processing 
Anterior segment quadrants of fixed porcine eyes were cut into 3 mm wide 
meridional wedges and trimmed to isolate the outflow region. The tissue was dehydrated 
through an ethanol series, infiltrated and embedded in Histocryl media (Electron 
Microscopy Sciences).  Two µm thick sections were cut on a Leica UC7 ultramicrotome 
with a glass knife and examined with a Leica DM6 Epifluorescent microscope. Sections 
were then stained with Toluidine blue (Sigma-Aldrich), mounted with Prolong Gold 
(ThermoFisher) and examined to assess cell morphology and tissue structure.  
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6.3.6.4 Gelatin Zymography 
During organ culture experiments, 1mL of media that had passed through the 
outflow tract was collected by aspiration from the organ culture dish daily (“conditioned 
outflow media”). The remaining media in the organ culture dish was discarded daily. 
Media was collected before H2O2 treatment and throughout the IOP homeostasis 
challenge and was stored at -80oC prior to use.  
Media was assessed for gelatinase activity (MMP-2 and MMP-9) by gelatin 
zymography (Chen and Platt, 2011; Raykin et al., 2017). Briefly, samples were 
supplemented with 4x non-reducing sample dye (250 mM Tris-HCl, pH 6.8; 40% (v/v) 
glycerol; 8% (w/v) SDS; and 0.01% (w/v) bromophenol blue) and were loaded at 5 µL 
per lane onto 10% SDS-polyacrylamide gels with 0.2% (w/v) gelatin. SDS-PAGE was 
run at 125 V for approximately 90 minutes at room temperature in running buffer (25 mM 
Tris, 192 mM Glycine, 0.1% (w/v) SDS, pH 8.3, BioRad). Gels were removed and placed 
in 2.5% (v/v) Triton X-100 to renature enzymes for 30 minutes, then incubated in 50 mM 
Tris-HCl, 150 mM NaCl, 10 mM CaCl2, pH 7.8 overnight to allow sufficient time for 
gelatinolytic activity to occur. Following overnight incubation at 37oC, the gels were 
incubated with Coomassie stain (0.05% (w/v) Coomassie Brilliant Blue G-250, 25% (v/v) 
methanol, 10% (v/v) acetic acid) for 1 hour, followed by destaining (4% (v/v) methanol, 
8% (v/v) acetic acid) until clear bands were visible, at which time the gels were imaged. 
Total gelatinase activity was quantified using ImageQuant TL 8.1 (GE Healthcare Life 
Sciences).  
6.3.7 Stem Cell Delivery to the TM 
To determine the effects of stem cells on the H2O2-treated TM, stem cells were 
injected into organ-cultured anterior segments 24 hours after H2O2 treatment. Adipose-
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derived MSCs were detached from culture dishes with 0.05% Trypsin-EDTA, centrifuged 
and labeled by resuspending in 5µM carboxyfluorescein succinimidyl ester (CFSE, 
affymetrix eBioscience) in PBS. After incubating for 15 minutes at 37oC, MSC media was 
added to quench any unreacted CFSE before injection into the anterior segment. Cells 
were resuspended in organ culture media, and 1 million cells in 500µL were injected 
(~10 second injection) through the cornea while anterior segments were pressure 
clamped at 6 to 12 mmHg by connection to an open reservoir. Perfusion at 2.5µL/min 
was resumed immediately after injection and continued overnight to allow time for cell 
delivery, after which anterior segments were removed from dishes and fixed in 10% 
buffered formalin. The TM was imaged en face at 100x magnification at locations where 
CFSE-stained MSCs were observed.  
6.3.8 Statistics 
For in vitro experiments, at least 4 technical replicates for each of 2 pTM cell 
lines were assessed for each experiment setup. Analysis of variance (ANOVA, with post 
hoc Tukey test) was used to determine if untreated, control groups were significantly 
different from H2O2-treated groups. For ex vivo organ culture experiments, at least 6 
eyes were assessed for every experimental condition. Similarly, analysis of variance 
(ANOVA, with post hoc Tukey test) was used to determine if untreated, control groups 
were significantly different from H2O2-treated groups. Differences in baseline IOP for 
control and H2O2-treated groups was determine by a paired Student’s t-test. The 
significance threshold was taken as p = 0.05.  
The use of ANOVA requires three assumptions to be satisfied: the outcome of 
interest must be continuous and measurements must be independent; the residuals 
must be normally distributed; and there must be homogenous variance between groups 
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(“homoscedasticity”). For this study, all experimental variables were continuous. Uniform 
distribution and equal variances were routinely assessed as part of the ANOVA analysis 
(XLSTAT). Unfortunately, for situations in which there were small numbers of 
observations (n < 5), assessment of normality was unreliable. Further statistical analysis 
should be carried out to confirm the validity of these statistical tests.  
6.4 Results 
6.4.1 Effect of H2O2 on pTM Cell Viability in vitro 
Isolated pTM cells were treated with different concentrations of H2O2 for 1 hour 
and viability was measured by flow cytometry. Viability and H2O2 concentration were 
linearly correlated over a wide range (Figure 38A). Interestingly, cell viability continued to 
decrease beyond the initial 1 hour treatment with H2O2 until it stabilized at approximately 
24 hours after H2O2 exposure (Figure 38B). Further, cellular viability was similar in three 
pTM cell lines following 1 hour treatment with 2 mM H2O2 and 24-hour incubation in 
organ culture media to account for extended H2O2 induced death (Figure 38C). We 
conclude that H2O2 treatment of pTM cells is capable of consistently producing titrated 




Figure 38. Effects of H2O2 Treatment on pTM Cells in vitro. (A) Effect of H2O2 
concentration on pTM cell viability immediately after 1 hour exposure (n = 4 technical 
replicates). (B) Extended effects of 2mM H2O2 treatment for 1 hour on pTM cell viability, 
for two pTM cell lines (n=12 technical replicates). (C) Summary of effects of 1 hour, 2mM 
H2O2 treatment on 3 pTM cell lines (n=12 technical replicates). Box plot interpretation is 
as described in Figure 23. Mean values are shown for each pTM cell line in plot. Error 
bars denote standard deviation. All viability values were normalized to control conditions 
(no H2O2). 
6.4.2 Functional assessment of H2O2-treated pTM cells 
To assess the effects of H2O2 treatment on pTM cell function, cells were treated 
with 2mM H2O2 for 1 hour and allowed to equilibrate for 24 hours. Alamar Blue staining 
indicated a significant decrease in metabolic activity following treatment (Figure 39A). 
Phagocytic activity after incubation with pHrodo e.coli particles was slightly reduced 
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following H2O2 treatment, but this did not reach statistical significance (Figure 39B). 
Similarly, H2O2-treated cells showed only minor changes in contractility, as assayed by a 
gel contraction assay (Figure 39C). We conclude that while metabolic activity is reduced, 
phagocytic and contractile properties of surviving pTM cells are not altered following 
H2O2 treatment.  
 
Figure 39. Effect of H2O2 on pTM Cell Function. pTM cells were treated with 2mM 
H2O2 for 1 hour. After 24 hours, pTM cells were tested for (A) metabolic activity (n=6 
technical replicates), (B) phagocytic activity (n=3 technical replicates), and (C) collagen 
gel contractility (n=6 technical replicates). Black dashed lines denote untreated control 
results and error bars denote standard deviation. Box plot interpretation is as described 
in Figure 23. Significant differences (denoted by asterisks, p < 0.05) between H2O2-
treated cells and untreated controls was determined by ANOVA, with post-hoc Tukey. 
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6.4.3 IOP homeostasis after H2O2 treatment 
After characterizing H2O2 treatment in vitro, experiments were translated to 
porcine organ-cultured anterior segments. Different H2O2 concentrations were perfused 
into porcine anterior segments for 1 hour followed by a stabilization period in which IOP 
returned to pre-treatment levels for both H2O2- treated and untreated experiments. 
Differences between baseline IOP values for Control and H2O2-treated eyes were not 
significant (Table 4). Perfusion flow rate was then doubled to evaluate the ability of the 
TM to respond to this “2x flow challenge”, as described in the Methods section. 2mM to 
4mM H2O2 did not lead to significant TM dysfunction, i.e. elevated IOP eventually 
returned close to baseline levels following the 2x flow challenge (data not shown). 
However, 4.5mM H2O2 resulted in sustained IOP elevation for at least 3 days following 
the 2x flow challenge, indicating a loss of TM homeostatic response (Figure 40). This 
was further verified by gelatin zymography on effluent collected before and during the 2x 
flow challenge. Control eyes (no H2O2 exposure) exhibited significantly more gelatinase 
activity compared to H2O2-treated eyes (Figure 41) during the 2x flow challenge, 
indicating reduced extracellular remodeling capacity in H2O2-treated eyes. We conclude 








Table 4. Baseline IOP for Control and H2O2-treated eyes. Baseline IOP values were 
averaged for 10 hours of IOP readings for each untreated or H2O2-treated anterior 
segment (n = 9 for each condition) immediately prior to the 2x flow challenge. Average 
differences between each condition were not significant (p = 0.15) as determined by a 
paired Student’s t-test. Note that control and H2O2-treated eyes were not generally from 
the same animal, but were obtained and perfused at the same time, and thus can be 
treated as a “pair” within the meaning of the paired t-test. Such “pairs” are referred to as 
a “cohort” in the table. 
Eye Cohort 








1 6.2 0.3 13.2 0.3 
2 15.8 0.8 19.3 0.7 
3 19.8 0.4 11.3 0.4 
4 17.9 1.2 14.9 0.6 
5 15.8 0.5 10.8 0.2 
6 19.8 0.4 10.5 0.7 
7 15.9 0.4 9.0 0.4 
8 17.1 0.3 13.1 0.6 
9 10.4 0.4 10.3 0.4 
Group mean ± SD 15.4 ± 4.4 12.5 ± 3.1 
 
 
Figure 40. 2x Perfusion Flow Challenge after H2O2 Treatment. (A) Average IOP 
traces for H2O2-treated and control eyes. IOP traces are shown throughout the 2x 
perfusion flow challenge until IOP steady-state was reached. IOP was normalized to an 
eye-specific baseline IOP measured after treatment with H2O2 (experimental eyes) or 
media (control eyes); shaded region denotes standard error. N values indicate number 
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of eyes that have been averaged, accounting for different termination times for the 
experiments. (B) Normalized steady-state (~48 hours after H2O2 treatment) IOP after 2x 
flow challenge in H2O2-treated and control eyes (n=9 eyes for each). Box plot 
interpretation is as described in Figure 23. Mean values for control and H2O2-treated 
eyes are shown in plot. Significance between H2O2-treated and untreated eyes was 
determined by ANOVA, post-hoc Tukey. 
 
Figure 41. Gelatinase Levels in Effluent Collected from Perfused Anterior 
Segments. (A) Representative zymogram for effluent from control and H2O2-treated 
anterior segments. (B) Total gelatinolytic activity is shown relative to pretreatment 
activity (N > 7 biological replicates for each). 5 µL of sample was run for each time point, 
and, after quantifying band intensity, 2x flow results were doubled to reflect the 
increased flow rate. Individual data points are shown and horizontal bars denote means. 
Mean values for each experimental group are shown in plot. Significance between H2O2 
treated and untreated eyes was determined by ANOVA, with post-hoc Tukey. 
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6.4.4 Live-Dead Assessment of Porcine TM After H2O2 Treatment 
Porcine TM tissue was assessed 24 hours after H2O2 treatment for cellular 
viability using calcein-AM and ethidium homodimer-1 staining. Reduced numbers of 
living cells and increased dead signal in the TM region of H2O2-treated eyes was 
observed compared to control, untreated eyes (Figure 42 A, B). H2O2 effects were highly 
segmental, resulting in certain regions appearing fully dead, while others showed 
minimal dead staining. This is likely due to the known segmental nature of outflow 
through the TM (Chang et al., 2014; Swaminathan et al., 2014). Live to dead fluorescent 
signal ratios were calculated for the entire TM region and the cornea. Although reduced 
live-dead ratios were consistently observed in H2O2-treated eyes, these differences did 
not reach statistical significance (Figure 42C).  
However, dead staining may not properly capture reduced TM cell viability. 
Ethidium homodimer-1 was often not seen in regions of the TM which were also Calcein-
AM negative. H2O2 damage is known to signal apoptosis in other tissues and eventual 
nucleus fragmentation, possibly resulting in minimal dead staining even though viability 
is reduced (Das et al., 2001; Liu et al., 2013; Nandi et al., 2010; Teramoto et al., 1999). 
As a result, live fluorescent signal intensities were compared to avoid inconsistencies in 
dead staining (Figure 42D). Significantly reduced live staining was observed in the TM 





Figure 42. Live-dead Staining in H2O2-treated Porcine Anterior Segments. 
Representative en face images for the entire TM region of (A) control and (B) H2O2-
treated porcine anterior segments. Calcein-AM (Green) and Ethidium homodimer (Red) 
denote live and dead cells, respectively. Scale bars are 2mm. (C-D) Quantification of 
Live and Dead fluorescent label intensities in the TM and cornea regions for H2O2-
treated and control anterior segments (n=9 anterior segments each). (C) Live-dead 
fluorescent signal intensity ratios relative to controls and (D) Live cell signal intensities 
relative to controls are shown. Box plot interpretation is as described in Figure 23. 
Significance between H2O2-treated and untreated eyes was determined by ANOVA, with 
post-hoc Tukey. 
6.4.5 Histological Assessment of H2O2-Treated Eyes 
Following H2O2 treatment, corneal swelling was qualitatively monitored in organ 
culture as evidenced by reduced corneal transparency. Corneal swelling indicates 
damage to the corneal endothelium and results in cytokine and MMP secretion that may 
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confound stem cell therapy results (Joyce et al., 2011; Li and Pflugfelder, 2005; 
Macdonald et al., 1987; Philipp et al., 2000). One day after H2O2 treatment, reduced 
transparency was not observed. For 2x flow experiments where H2O2 eyes were 
maintained for 3 – 4 days after treatment, corneal swelling was infrequent, similar to 
untreated eyes.  
Sagittal sections from fixed porcine eyes after live-dead imaging were assessed 
to determine whether H2O2 treatment altered the TM microarchitecture. Tissue was 
stained with toluidine blue to identify cell nuclei and better visualize TM extracellular 
matrix. Two anterior segment quadrants from each of three H2O2-treated and untreated 
control eyes were processed. TM microarchitecture was not found to be disrupted by 
H2O2 when compared to untreated eyes (Figure 43). The number of cell nuclei in the TM 
were also similar between H2O2-treated and untreated eyes across all processed eyes. 




Figure 43. Histological Assessment of TM After H2O2 Treatment.  Representative 
toluidine blue stained sagittal sections of the TM region for (A,C) H2O2-treated organ-
culture porcine anterior segments and (B,D) untreated control anterior segments. (A,B) 
Lower magnification brightfield micrographs are labeled with relevant anatomical 
features for orientation (AAP = angular aqueous plexus, an analogue of Schlemm’s 
canal in porcine eyes).  Approximate zoomed regions are shown as blue and red boxes  
6.4.6 MSC Delivery to H2O2-Treated Anterior Segments  
Stem cells were delivered into anterior segments following H2O2 treatment to 
determine what effect, if any, H2O2 damage had on stem cell engraftment in the TM. 
MSCs were consistently found at similar amounts in H2O2-treated anterior segments and 
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untreated anterior segments. However, MSC morphology in the TM was noticeably 
different in H2O2-treated eyes, with more elongated cellular bodies compared to a 
rounded morphology in control eyes (Figure 44). This suggests that MSC engraftment in 
the TM occurred more prevalently in H2O2-treated eyes compared to control eyes. This 
was likely due to there being more binding sites in the TM of H2O2-treated anterior 
segments due to lower TM cellularity.  
 
Figure 44. MSC Delivery to the TM in H2O2-Treated Anterior Segments. CFSE-
labeled MSCs were injected at 1 million cells per anterior segment and allowed to 
adhere overnight. Representative en face fluorescent micrographs for (A) untreated and 
(B) H2O2-treated organ culture anterior segments.  
6.5 Discussion 
This work demonstrates that it is possible to create a pathophysiologically 
accurate model of TM dysfunction in commonly available porcine anterior segments. 
Such a model is expected to be useful for several reasons. First, reduced TM cellularity 
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in glaucoma is believed to cause tissue dysfunction, specifically increased outflow 
resistance leading to OHT. As a result, this model offers a suitable platform to test stem 
cell therapies to restore the cellularity and functionality of the TM. In this context, use of 
porcine anterior segments is attractive since they offer a more manageable TM size 
compared to rodents, and findings in this model are likely highly translatable to human 
eyes when eye size-dependent physical factors influencing stem cell delivery are 
considered.  
We used H2O2 treatment, an acute model of oxidative stress, to induce TM 
dysfunction in porcine anterior segment organ culture. Oxidative stress is believed to 
contribute to the pathogenesis of POAG, and leads to DNA, mitochondrial, and 
extracellular matrix damage in the TM (Clopton and Saltman, 1995; Knepper et al., 
1996; Sacca et al., 2005; Tanito et al., 2016; Yu et al., 2008; Zhao et al., 2016). 
Interestingly, the TM has been found to be more susceptible to oxidative damage than 
other anterior ocular tissues, such as the cornea (Izzotti et al., 2009).   
Key features of this model include reduced TM cellularity, and a concomitant loss 
of IOP homeostasis after a flow challenge. Consistent with this loss of homeostasis, we 
observed reduced gelatinase (MMP-2 and MMP-9) activity in H2O2-treated anterior 
segments. TM cells have been previously shown to upregulate secretion of MMP-2, -3 
and -14 after IOP elevation, all of which are involved in extracellular matrix remodeling 
(De Groef et al., 2013). Reduction of MMP-2 expression, as observed by gelatin 
zymography in media effluent, indicates reduced tissue remodeling after elevated IOP in 
H2O2 eyes. The reduction in gelatinase activity was not in response to H2O2 treatment, 




Organ-cultured porcine anterior segments had a significant reduction in cellularity 
after 4.5mM H2O2 treatment, as determined by live-dead staining, with cell viability 
reduced to c. 35% of that seen in controls. This seems to be somewhat more severe 
than the situation in human glaucomatous tissue, where approximately 30% fewer cells 
are found in the TM of POAG donors compared to similarly aged healthy eyes (Alvarado 
et al., 1984; Liton et al., 2005). However, the porcine anterior segments are presumably 
from young adult pigs, and TM cells are lost continuously with age. Considering a 
reduction in TM cellularity associated with aging from 0 to 80 years of approximately 
60% (Alvarado et al., 1981), we estimate that there are approximately 70 to 80% fewer 
TM cells in aged glaucomatous human eyes compared to young, healthy human tissue. 
This figure is quite close to the 65% mean decrease we observed after H2O2 treatment in 
porcine anterior segments. Interestingly, loss of IOP homeostasis was utilized as our 
endpoint to determine the optimal H2O2 concentration, which perhaps not coincidentally 
resulted in a TM cellularity reduction similar to that seen in human glaucoma in aged 
eyes. 
Importantly, our acute oxidative stress model resulted in minimal unwanted side 
effects on tissue morphology and the function of the remaining TM cells. For example, 
histology revealed a grossly normal-appearing TM after H2O2 treatment, suggesting 
tissue integrity was maintained, essential for assessing stem cell therapies. However, 
due to cellularity effects of H2O2 being segmental, more histological assessment is 
needed to confirm regions of damage are properly assessed. Second, phagocytic and 
cell contractility functions of the remaining TM cells were not significantly altered after 
H2O2 treatment. This is broadly consistent with the clinical situation, where phagocytic 
function appears to be preserved in TM cells during glaucoma (Matsumoto and Johnson, 
1997).   
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Our oxidative stress model was also compatible with MSC delivery to the TM. In 
fact, H2O2-treated eyes showed better engraftment of MSCs compared to delivery in 
untreated eyes. After H2O2 treatment, TM cell numbers were reduced to 35%, compared 
to untreated, control anterior segments. We believe this reduced cellularity “made 
available” binding sites in the TM for MSCs to adhere to, which were not available in 
untreated, control eyes. For stem cell therapies, proper MSC engraftment is essential for 
subsequent differentiation and refunctionalization of the TM.  
There are several limitations to this model. H2O2-induced damage of the TM was 
non-specific and, as a result, other anterior chamber tissues exhibited reduced 
cellularity. This might lead to confounding factors when testing cell therapies. The non-
specificity of H2O2 effects also means this approach is likely not suitable for in vivo 
applications. Nonetheless, this model shows great promise for testing mesenchymal 
stem cell therapies in cultured porcine anterior segments.   
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CHAPTER 7.   CONCLUSIONS 
Mesenchymal stem cell therapies represent a new, largely unstudied, therapeutic 
approach for repairing the TM in glaucoma, and, as such, methods and procedures for 
assessing differentiation, delivering cells to the eye, and assessing these cells’ 
therapeutic potential for glaucoma have not yet been established. The objective of this 
thesis was to develop these essential first steps so that mesenchymal stem cell 
therapies for glaucoma can be properly assessed and implemented.  Towards this 
objective, four specific aims were defined, and conclusions, limitations, and future 
directions from each aim are described below: 
Specific Aim 1:  Characterize differences between mesenchymal stem cells and 
trabecular meshwork cells at the RNA, protein, and functional levels 
A first step towards developing MSC therapies for glaucoma is confirming that 
MSCs are capable of differentiation to a TM-like cell phenotype. However, this step 
cannot be achieved without first standardizing the assessment of differentiation. Using 
human MSCs and TM cells, we characterized differences at the messenger (RT-qPCR), 
protein (western blotting, flow cytometry), and functional (gel contractility and 
phagocytosis) levels. RT-qPCR offered a relatively high-throughput assay for initial 
assessment of differentiation, while measurement of myocilin protein expression after 
dexamethasone treatment was in accordance with standard TM cell characterization 
protocols. MSC therapies will only be viable if differentiated cells are functionally similar 
to TM cells, and these methods allow for testing contractile and phagocytic properties, 
key TM functions in vivo.  
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With differentiation assessment standardized in this manner, future research can 
examine MSC differentiation to a TM-like cell phenotype through co-culture with human 
or porcine TM cells. Co-culture conditions have been used to differentiate induced 
pluripotent stem cells into TM cells, so this is a natural starting point for MSC 
differentiation (Abu-Hassan et al., 2015; Ding et al., 2014). Three different schemes will 
be used to differentiate MSCs, each representing a different degree of co-culture 
interaction. MSCs and TM cells can be grown together to allow differentiation to be 
driven by cell-cell interactions, paracrine signaling, and innately secreted proteins from 
TM cells. Cell-cell interaction can be removed by growing TM cells in Transwell inserts 
so that both cell types share media but are not in contact with each other. Further 
isolation is possible by treating MSCs with conditioned media from TM cells grown alone 
to assess the role of only innate protein secretion. These experiments will provide insight 
into whether MSCs can differentiate into TM cells as well as the required level of 
interaction to induce a TM cell phenotype.  
Specific Aim 2: Implement an ultrasound-photoacoustic imaging platform for visualizing 
mesenchymal stem cell delivery and retention in the trabecular meshwork 
We implemented an ultrasound and photoacoustic imaging platform capable of 
non-invasive, real-time detection of MSC delivery to TM. MSC delivery, based on two 
previous studies (Manuguerra-Gagne et al., 2013; Roubeix et al., 2015), is a challenging 
process, and this platform has the potential to expedite optimization of MSC delivery and 
simplify therapeutic assessment. Spectroscopic PA imaging allowed for detection of gold 
nanosphere-labeled MSCs, while ultrasound imaging provided anatomical details of the 
anterior segment. MSCs were tracked during injection into porcine eyes and were 
distinguishable from background PA signals from melanin-rich tissues for up to 5 hours 
after injection. However, MSC distribution in the TM region obtained with US-PA imaging 
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was not entirely consistent with the distribution measured using conventional fluorescent 
microscopy, and this remains an area of future work. 
While US-PA imaging has the potential to non-invasively track MSC delivery, as 
an alternative to histology and fluorescent microscopy, additional studies are needed to 
improve TM imaging and correlation with more standard fluorescent imaging. Currently, 
delivering light to the TM region is difficult, due to the TM being recessed in the anterior 
chamber angle and the lens naturally focusing light away from the angle. Results from 
this study were mostly conducted with dissected eyes to bypass this light delivery hurdle. 
However, such an approach is not suitable for in vivo studies. To improve light delivery, 
a gonio lens, a commonly used device for reflecting laser light delivery to the anterior 
chamber angle in glaucoma therapies, can be used (Barkana and Belkin, 2007; Ho et 
al., 2009).  
While US-PA and fluorescent imaging of MSC in the TM were somewhat 
consistent, there was high variability. This could be due to a number of confounding 
factors present in imaging complex porcine tissues with US-PA. We suggest simplifying 
the problem by first imaging labelled cells in gelatin phantoms, instead of in porcine 
eyes. MSCs will be placed in gelatin constructs and imaged by US-PA and fluorescence 
microscopy. Correlations between these two imaging modalities will be examined to 
determine whether variation is reduced, and to better “calibrate” the US-PA imaging of 
labelled cells.   
Finally, longitudinal studies will be conducted to properly track MSC dynamics 
after delivery. It is unknown whether MSCs are retained long-term in the TM, whether 
they migrate within in the TM over time, and/or whether they proliferate in situ. Unlike 
fluorescent microscopy, US-PA imaging has the potential to track each of these 
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possibilities in the same experimental eye. MSC delivery and in vivo experiments are 
inherently variable, so being able to assess multiple time points in a single eye will 
simplify translation of MSC therapies for the TM.  
Specific Aim 3: Improve mesenchymal stem cell delivery to the trabecular meshwork 
using magnetic nanoparticles 
While US-PA allows for monitoring MSC delivery to the TM, it does not improve 
delivery efficiency. In fact, US-PA imaging results suggested that when cells were 
delivered passively by aqueous outflow, most MSCs fell under the action of gravity, 
settling on the anterior lens and iris. Thus, we assessed whether magnetically steered 
delivery of MSCs labeled with Prussian blue nanocubes (PBNCs) led to a better 
outcome. PBNCs were found to be suitable for MSC labeling, resulting in minimal toxicity 
effects in MSCs and no detectable impact on the cell’s ability to differentiate toward 
adipogenic or osteogenic lineages. To magnetically steer MSCs to the TM, larger 200nm 
PBNCs were found to be most effective. Further, magnetic steering was rapid, with 
magnetic exposure times of as little as 15 minutes showing large effects on MSC 
delivery. One key issue in passive, conventional MSC delivery to the TM is segmental 
delivery to active flow regions of the TM. Magnetic steering of MSCs using a ring magnet 
resulted in relatively uniform delivery around the entire TM circumference. This approach 
for enhancing cell delivery has the potential to improve MSC-based therapies for the TM.  
Future work will use PBNCs in the US-PA platform described in Specific Aim 2. 
This, however, will only be possible if PBNC-MSCs are distinguishable from 
endogeneous PA signal. Experiments similar to our AuNS-MSC experiments will thus be 
conducted to confirm PBNC-MSCs can be tracked and that results agree with 
fluorescence microscopy. In addition, PBNC labeling will be used in rodents to facilitate 
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in vivo delivery of MSCs to the TM. Magnet design and placement, and exposure 
duration, will need to be optimized for delivery to a smaller eye. Fortunately, radial-
pulling ring magnets are commercially available that fit the smaller rodent eye, which 
was not the case for porcine eye.  
Specific Aim 4: Develop an oxidative stress-derived porcine organ-culture glaucoma 
model mimicking trabecular meshwork damage and cell loss 
Most current glaucoma models do not replicate the reduced TM cellularity seen 
in human glaucoma. Instead, existing models permanently damage or clog the outflow 
region, which is not suitable for assessing TM stem cell therapies. Here, we developed a 
porcine organ-culture model and used hydrogen peroxide to induce oxidative stress in 
the trabecular meshwork, thus partially decellularizing the TM. Following hydrogen 
peroxide treatment, eyes were challenged with increased fluid flow to assess the TM’s 
ability to homeostatically maintain IOP. In response to this challenge, control eyes were 
able to increase outflow through the TM via MMP-mediated remodeling, while hydrogen 
peroxide-treated eyes were not able to do so. Further, live-dead staining and histology 
confirmed reduced TM cellularity in treated eyes without extensive structural damage to 
the TM, similar to the situation in human glaucoma. As a result, this glaucoma model is 
suitable for testing stem cell therapies to assess their potential for restoring function to 
the TM.  
Future work will use this organ-culture model to assess actual MSC therapies. 
Hydrogen peroxide-treated anterior segments should be characterized at relevant time 
points for MSC differentiation. Ideally, MSCs will be injected into hydrogen peroxide-
damaged anterior segments, and, after engraftment, MSCs will differentiate into a TM 
cell-like phenotype. However, the time course for this process is unknown until co-
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culture differentiation experiments are conducted. Experiments with hydrogen peroxide-
treated anterior segments have not been extended beyond one week after hydrogen 
peroxide delivery. If longer time points are needed, porcine anterior segments need to 
be characterized for TM dysfunction, viability and structural integrity for longer durations. 
We do not anticipate any issues for durations less than 3-4 weeks. However, maintaining 
viable anterior segments in organ culture beyond 3-4 weeks is very difficult. As an 
alternative, should longer time points be problematic for this model, MSCs could be 
differentiated in vitro to TM cells prior to injection. 
Final Thoughts 
This dissertation has taken the first steps towards testing future MSC-based therapies 
for repairing the glaucomatous TM. The findings from this dissertation will allow 
researchers to define initial in vitro differentiation, optimize delivery, and assess efficacy 
of proposed therapies for the TM, bringing clinical translation of MSC therapies for the 
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